Bloomia Holdings, Inc 10-Q for FY2024 Q3
Bloomia Holdings, Inc. (TULP)
About this 10-Q
Bloomia Holdings, Inc filed this 10-Q on May 21, 2024, covering the quarter ended March 31, 2024 (FY2024 Q3).
Headline figures
Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $8.03M
- compared with $0 a year earlier
- Net loss
- $1.26M
- compared with net income of $1.65M a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
for the quarterly period ended
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
for the transition period from ___________ to ____________
Commission File Number:
(Exact name of registrant as specified in its charter) |
| ||
(State or other jurisdiction of incorporation or organization) |
| (I.R.S. Employer Identification No.) |
(Address of principal executive offices; zip code)
(
(Registrant’s telephone number, including area code)
Securities registered to Section 12(b) of the Act:
Title of each class |
| Trading Symbol |
| Name of each exchange on which registered |
|
| The |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.:
Large accelerated filer | ☐ | Accelerated filer | ☐ |
☒ | Smaller reporting company | ||
|
| Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
Number of shares outstanding of Common Stock, $.01 par value, as of May 17, 2024 was
Lendway, Inc.
TABLE OF CONTENTS
| 2 |
| Table of Contents |
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
Lendway, Inc. and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEETS
|
| March 31, 2024 |
|
|
| |||
|
| 2024 |
|
| December 31, |
| ||
|
| (Unaudited) |
|
| 2023 |
| ||
| Assets |
|
|
|
|
|
| ||
| Current assets: |
|
|
|
|
|
| ||
| Cash and cash equivalents |
| $ |
|
| $ |
| ||
| Accounts receivable, net |
|
|
|
|
|
| ||
| Receivable from escrow account |
|
|
|
|
|
| ||
| Inventories, net |
|
|
|
|
|
| ||
| Prepaid expenses and other current assets |
|
|
|
|
|
| ||
| Other current assets related to discontinued operations |
|
|
|
|
|
| ||
| Total current assets |
|
|
|
|
|
| ||
| Property and equipment, net |
|
|
|
|
|
| ||
| Equity-method investment |
|
|
|
|
|
| ||
| Goodwill |
|
|
|
|
|
| ||
| Intangible assets, net |
|
|
|
|
|
| ||
| Operating lease right-of-use assets |
|
|
|
|
|
| ||
| Finance lease right-of-use assets |
|
|
|
|
|
| ||
| Long-term receivable |
|
|
|
|
|
| ||
| Note receivable |
|
|
|
|
|
| ||
| Other assets |
|
|
|
|
|
| ||
| Total assets |
| $ |
|
| $ |
| ||
|
|
|
|
|
|
|
|
|
| Liabilities and Stockholders' equity |
|
|
|
|
|
|
|
|
| Current liabilities: |
|
|
|
|
|
|
|
|
| Accounts payable |
| $ |
|
| $ |
| ||
| Accrued compensation |
|
|
|
|
|
| ||
| Accrued expenses and other current liabilities |
|
|
|
|
|
| ||
| Current portion of finance lease liabilities |
|
|
|
|
|
| ||
| Current portion of operating lease liabilities |
|
|
|
|
|
| ||
| Current portion of debt |
|
|
|
|
|
| ||
| Current liabilities related to discontinued operations |
|
|
|
|
|
| ||
| Total current liabilities |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
| Long-term liabilities: |
|
|
|
|
|
|
|
|
| Finance lease liabilities, net of current portion |
|
|
|
|
|
| ||
| Operating lease liabilities, net of current portion |
|
|
|
|
|
| ||
| Long-term debt, net |
|
|
|
|
|
| ||
| Deferred tax liabilities, net |
|
|
|
|
|
| ||
| Total Long-term liabilities |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
| Commitments and contingencies (Note 12) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholders' equity |
|
|
|
|
|
|
|
|
| Common stock, par value $.01: |
|
|
|
|
|
|
|
|
| Authorized shares - |
|
|
|
|
|
|
|
|
| Issued and outstanding shares - |
|
|
|
|
|
| ||
| Additional paid-in capital |
|
|
|
|
|
| ||
| Accumulated other comprehensive income |
|
|
|
|
|
| ||
| Accumulated deficit |
|
| ( | ) |
|
| ( | ) |
| Total stockholders' equity attributable to Lendway, Inc |
|
|
|
|
|
| ||
| Equity from noncontrolling interest |
|
|
|
|
|
| ||
| Total Stockholders' equity |
|
|
|
|
|
| ||
| Total Liabilities and Stockholders' equity |
| $ |
|
| $ |
| ||
See accompanying notes to the condensed consolidated financial statements.
| 3 |
| Table of Contents |
Lendway, Inc. and Subsidiaries
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
(Unaudited)
|
| Three Months Ended |
| |||||
|
| March 31, |
|
| March 31, |
| ||
| Revenue, net |
| $ |
|
| $ |
| ||
| Cost of goods sold |
|
|
|
|
|
| ||
| Gross profit |
|
|
|
|
|
| ||
| Sales, general and administrative expenses |
|
|
|
|
|
| ||
| Operating loss |
|
| ( | ) |
|
| ( | ) |
| Foreign exchange difference, net |
|
| ( | ) |
|
|
| |
| Interest expense (income), net |
|
|
|
|
| ( | ) | |
| Other expenses, net |
|
|
|
|
|
| ||
| Loss from continuing operations before income taxes |
|
| ( | ) |
|
| ( | ) |
| Income tax (benefit) expense |
|
| ( | ) |
|
|
| |
| Net loss from continuing operations |
|
| ( | ) |
|
| ( | ) |
| Income from discontinued operations, net of tax |
|
|
|
|
|
| ||
| Net (loss) income including noncontrolling interest |
|
| ( | ) |
|
|
| |
| Less: Net (loss) income attributable to noncontrolling interest |
|
| ( | ) |
|
|
| |
| Net (loss) income attributable to Lendway, Inc. |
|
| ( | ) |
|
|
| |
| Other comprehensive income (foreign currency translation) |
|
|
|
|
|
| ||
| Comprehensive (loss) income attributable to Lendway, Inc. |
| $ | ( | ) |
| $ |
| |
|
|
|
|
|
|
|
|
|
| Net (loss) income per basic and diluted share attributable to Lendway, Inc.: |
|
|
|
|
|
|
|
|
| Continuing operations |
| $ | ( | ) |
| $ | ( | ) |
| Discontinued operations |
|
|
|
|
|
| ||
| Basic and diluted earnings per share |
| $ | ( | ) |
| $ |
| |
|
|
|
|
|
|
|
|
|
| Shares used in calculation of net (loss) income per share: |
|
|
|
|
|
|
|
|
| Basic and diluted |
|
|
|
|
|
| ||
See accompanying notes to the condensed consolidated financial statements.
| 4 |
| Table of Contents |
Lendway, Inc. and Subsidiaries
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited)
|
|
|
|
|
|
|
|
|
|
| Accumulated |
|
|
|
|
| Total |
|
|
|
|
|
|
| ||||||||
|
|
|
|
|
| Additional |
|
| Other |
|
|
|
| Lendway |
|
|
|
| Total |
| ||||||||||||
|
| Common Stock |
|
| Paid-In |
|
| Comprehensive |
|
| Accumulated |
|
| Stockholders' |
|
| Noncontrolling |
|
| Stockholders' |
| |||||||||||
|
| Shares |
|
| Amount |
|
| Capital |
|
| Income |
|
| Deficit |
|
| Equity |
|
| Interest |
|
| Equity |
| ||||||||
| BALANCE DECEMBER 31, 2023 |
|
|
|
| $ |
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ |
|
| $ |
| |||||||
| Value of stock-based compensation |
|
| - |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
| Net loss |
|
| - |
|
|
|
|
|
|
|
|
|
|
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) | |||
| Other comprehensive income |
|
| - |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
| Issuance of noncontrolling interests in acquisition |
|
| - |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
| BALANCE MARCH 31, 2024 (Unaudited) |
|
|
|
| $ |
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ |
|
| $ |
| |||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BALANCE DECEMBER 31, 2022 |
|
|
|
| $ |
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ |
|
| $ |
| |||||||
| Issuance of common stock, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
| Value of stock-based compensation |
|
| - |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
| Net income |
|
| - |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
| BALANCE MARCH 31, 2023 (Unaudited) |
|
|
|
| $ |
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ |
|
| $ |
| |||||||
See accompanying notes to the condensed consolidated financial statements.
| 5 |
| Table of Contents |
Lendway, Inc. and Subsidiaries
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
| Three Months Ended |
| |||||
|
| March 31, |
|
| March 31, |
| ||
|
| 2024 |
|
| 2023 |
| ||
| Operating Activities |
|
|
|
|
|
| ||
Net (loss) income |
| $ | ( | ) |
| $ |
| |
Adjustments to reconcile net (loss) income to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
| ||
Amortization of deferred financing costs |
|
|
|
|
|
| ||
Changes in allowance for doubtful accounts |
|
|
|
|
|
| ||
Stock-based compensation expense |
|
|
|
|
|
| ||
Noncash operating lease expense |
|
|
|
|
|
| ||
Deferred income tax (benefit) expense |
|
| ( | ) |
|
|
| |
Increase (decrease) in cash resulting from changes in, net of acquisition: |
|
|
|
|
|
|
|
|
Accounts receivable, net |
|
| ( | ) |
|
| ( | ) |
Inventories |
|
|
|
|
|
| ||
Income tax receivable |
|
|
|
|
|
| ||
| Prepaid expenses and other current assets |
|
| ( | ) |
|
| ( | ) |
Accounts payable |
|
|
|
|
| ( | ) | |
Accrued compensation |
|
| ( | ) |
|
|
| |
| Accrued expenses and other current liabilities |
|
|
|
|
| ( | ) | |
| Deferred revenue |
|
|
|
|
| ( | ) | |
| Net cash provided by (used in) operating activities of continuing operations |
|
|
|
|
| ( | ) | |
| Net cash provided by operating activities of discontinued operations |
|
|
|
|
|
| ||
| Net cash provided by (used in) operating activities |
|
|
|
|
| ( | ) | |
|
|
|
|
|
|
|
|
|
Investing Activities |
|
|
|
|
|
|
|
|
Purchases of property and equipment |
|
| ( | ) |
|
| ( | ) |
| Acquisition of Bloomia, net of cash acquired |
|
| ( | ) |
|
|
| |
| Receipts from note receivable |
|
|
|
|
|
| ||
| Net cash used in investing activities |
|
| ( | ) |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
| Financing Activities |
|
|
|
|
|
|
|
|
| Proceeds from long-term debt |
|
|
|
|
|
| ||
| Repayments of long-term debt |
|
| ( | ) |
|
|
| |
Principal payments on finance lease liabilities |
|
| ( | ) |
|
|
| |
Payment of financing costs |
|
| ( | ) |
|
|
| |
Proceeds from issuances of common stock |
|
|
|
|
|
| ||
| Net cash provided by financing activities |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes |
|
|
|
|
|
| ||
Net decrease in cash and cash equivalents |
|
| ( | ) |
|
| ( | ) |
Cash and cash equivalents, beginning of period |
|
|
|
|
|
| ||
Cash and cash equivalents, end of period |
| $ |
|
| $ |
| ||
|
|
|
|
|
|
|
|
|
Supplemental cash flow information |
|
|
|
|
|
|
|
|
Cash paid for interest |
| $ |
|
| $ |
| ||
| Noncash purchase consideration - Equity issuance of noncontrolling interest |
| $ |
|
| $ |
| ||
| Noncash purchase consideration - Seller notes |
| $ |
|
| $ |
| ||
See accompanying notes to the condensed consolidated financial statements.
| 6 |
| Table of Contents |
Lendway, Inc. and Subsidiaries
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Description of Business and Basis of Presentation.
Description of Business. Lendway, Inc. (“the Company”) has evolved into a specialty agricultural (“ag”) and finance company focused on making and managing its ag investments in the United States (“U.S.”) and internationally. On February 22, 2024, the Company, through its majority-owned U.S. subsidiary Tulp 24.1, LLC (“Tulp 24.1”), acquired Bloomia B.V. (“Bloomia”). Subsequent to the purchase of Bloomia, the Company’s primary operations will be that of Bloomia. Bloomia is a significant producer of fresh cut tulips in the U.S. with a presence in the Netherlands and South Africa. As part of consideration for the business combination, the Company issued units of Tulp 24.1 to the continuing CEO of Bloomia, which amounted to 18.6% and is presented as noncontrolling interest in these condensed consolidated financial statements. The remaining 81.4% equity interest of Tulp 24.1 is owned by the Company and the Company is and maintains control of Tulp 24.1 as its sole managing member. Refer to Note 3 for further discussion. The Company has retained its non-bank lending business via its wholly owned subsidiary, Farmland Credit, Inc. (“FCI”), and FCI’s subsidiaries, Farmland Credit FR, LLC and Farmland Credit AV, LLC. As part of its non-bank lending business, the Company operates FarmlandCredit.com, a non-bank lending business that seeks to purchase existing loans and/or originate and fund new loans domestically.
Basis of Presentation. The accompanying unaudited condensed consolidated financial statements of the Company include all wholly and majority owned subsidiaries of the Company. The operations of Bloomia are included since the date of acquisition. Entities for which the Company owns an interest, does not consolidate, but exercises significant influence, are accounted for under the equity method of accounting and are included in equity method investments within the condensed consolidated balance sheets. All intercompany accounts and transactions have been eliminated. These unaudited condensed consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Securities and Exchange Commission (“SEC”) Regulation S-X and do not include all information and footnotes required by U.S. GAAP for complete financial statements. However, except as described herein, there has been no material change in the information disclosed in the notes to financial statements included in the Company’s consolidated financial statements as of and for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K filed with the SEC on April 1, 2024 (the Form 10-K). In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement have been included. The accompanying condensed consolidated balance sheet as of December 31, 2023 has been derived from the audited balance sheet as of December 31, 2023 contained in the Form 10-K; however, certain prior period amounts have been reclassified to conform to current period classification. Reclassifications had no material effect on prior year net income, net income (loss) per share, or stockholders’ equity.
The unaudited condensed consolidated results of operations and comprehensive loss for the three months ended March 31, 2024, are not necessarily indicative of results to be expected for the full fiscal year ending December 31, 2024, nor for any other future annual or interim period. The tulip sales business tends to be seasonal with spring being the strongest sales season.
On August 3, 2023, the Company completed the sale of certain assets and certain liabilities relating to the Company’s legacy business of providing in-store advertising solutions to brands, retailers, shopper marketing agencies and brokerages (the “In-Store Marketing Business”). The operations of the In-Store Marketing Business are presented as discontinued operations. All prior periods presented have been restated to present the In-Store Marketing Business as discontinued operations.
| 7 |
| Table of Contents |
Recently Issued Accounting Pronouncements. In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 requires enhanced disclosures about significant segment expenses, includes enhanced interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, provides new segment disclosure requirements for entities with a single reportable segment, and contains other disclosure requirements. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. ASU 2023-07 is to be applied retrospectively to all prior periods presented in the financial statements. The Company will not early adopt, and is currently assessing the impact of ASU 2023-07 on its consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 requires public companies to expand their income tax disclosures with respect to the reconciliation of the effective tax rate to the statutory rate for federal, state, and foreign income taxes and requires greater detail about significant reconciling items in the reconciliation. Additionally, the amendment requires disaggregated information pertaining to taxes paid, net of refunds received, for federal, state, and foreign income taxes. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted for annual financial statements that have not yet been issued, and allows for either a prospective or retrospective approach on adoption. The Company will not early adopt, and is currently assessing the impact of ASU 2023-07 on its consolidated financial statements and related disclosures.
2. Significant Accounting Policies.
Use of Estimates. The preparation of condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The key estimates made by management include the determination of fair values in conjunction with the acquisition of our majority interest in Bloomia, and the carrying value of inventories, right-of-use assets and lease liabilities, useful lives for property and equipment and intangible assets, and value of income taxes. Actual results could differ from these estimates.
Foreign Currency Transactions. The revenues of the Company and most of its subsidiaries are generated in U.S. dollars. In addition, most of the costs of the Company and most of its subsidiaries are incurred in U.S. dollars. The Company’s management has established that the U.S. dollar is the primary currency of the economic environment in which the Company and most of its subsidiaries operate. Thus, the functional currency of the Company and most of its subsidiaries is the U.S. dollar.
Transactions and balances that are denominated in currencies that differ from the functional currencies have been remeasured into U.S. dollars in accordance with principles set forth in Accounting Standards Codification (“ASC”) 830, Foreign Currency Matters. At each balance sheet date, monetary items denominated in foreign currencies are translated at exchange rates in effect at the balance sheet date, while income and expenses are translated at average exchange rates for the periods presented. All exchange gains and losses from the remeasurement mentioned above are reflected in the condensed consolidated statement of operations as foreign exchange expenses or income, as appropriate.
For subsidiaries whose functional currency has been determined to be other than the U.S. dollar, assets and liabilities are translated at year-end exchange rates, and condensed consolidated statement of operations items are translated at average exchange rates prevailing during the year, and equity is translated at blended historical rates. Resulting translation differences are recorded as a separate component of accumulated other comprehensive income (loss) in stockholders’ equity.
Accounts Receivable, Net. Accounts receivable are presented in the balance sheets at their outstanding balances net of the allowance for credit losses. These receivables are generally trade receivables due in one year or less or expected to be billed and collected in one year. The Company estimates credit losses on accounts receivables in accordance with ASC 326 Financial Instruments - Credit Losses. The Company measures the allowance for credit losses on trade receivables on a collective (pool) basis when similar risk characteristics exist. The estimate for allowance for credit losses is based on a historical loss rate for each pool. Management considers qualitative factors such as change in economic factors, regulatory matters, and industry trends to determine if an allowance should be further adjusted. At March 31, 2024, the Company had an allowance for doubtful accounts of approximately $
Inventories. Raw materials consist primarily of tulip bulbs, including freight and packaging supplies. Work-in-process consists of tulip stems and bulbs that have rooted. Inventories are stated at the lower of cost, as determined on the first-in, first-out method, or net realizable value. Finished goods and work-in-process include the inventory costs of raw materials, direct labor and normal manufacturing overhead. Abnormal amounts of spoilage are expensed as incurred and not included in overhead.
| 8 |
| Table of Contents |
Property and Equipment, Net. Property and equipment, net are stated at historical cost, less accumulated depreciation and amortization. Bushes refer to peony plants, which accumulate planting and development costs that are capitalized into their basis until they become commercially productive, at which point the asset begins depreciating, and future maintenance costs are expensed as incurred. Planting costs consist primarily of the costs to purchase and plant nursery stock. Development costs consist of cultivation, pruning, irrigation, labor, spraying and fertilization, and interest costs during the development period. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the remaining lease term (including renewals that are reasonably certain to occur) or the estimated useful lives of the improvements. The estimated useful lives of property and equipment are as follows:
Estimated Useful life | |
Machinery and equipment | |
Leasehold improvements | |
Bushes | |
Vehicles | |
Furniture and fixtures |
Long-Lived Assets Impairment Testing. Long-lived assets, which include property, plant and equipment, finite-lived intangible assets subject to amortization, and right-of-use assets are assessed for impairment whenever events or changes in circumstances such as asset utilization, physical change, legal factors or other matters indicate the carrying value of those assets may not be recoverable from future undiscounted cash flows. The impairment test involves comparing the carrying amount of each individual asset-group to the forecasted undiscounted future cash flows generated by that asset group. These assumptions require significant judgment and actual results may differ from assumed and estimated amounts. In the event the carrying amount of the asset exceeds the gross undiscounted future cash flows generated by that asset and the carrying amount is not considered recoverable, an impairment exists. An impairment loss is measured as the excess of an individual asset group’s carrying amount over its fair value and is recognized in the statement of operations in the period that the impairment occurs. The reasonableness of the useful lives of the asset and other long-lived assets is regularly evaluated. During the three months ended March 31, 2024 and 2023, no impairment losses were identified.
Goodwill and Indefinite-lived Assets. Goodwill results from business combinations and represents the excess of the purchase price over the fair value of acquired tangible assets and liabilities and identifiable intangible assets. Annually, or if conditions indicate an additional review is necessary, the Company assesses qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount and if it is necessary to perform the quantitative goodwill impairment test. If the Company performs the quantitative test, it compares the carrying value of the reporting unit to an estimate of the reporting unit’s fair value to identify potential impairment. The fair value of each reporting unit is estimated using a discounted cash flow model. Where available, and as appropriate, comparable market multiples also used to corroborate the results of the discounted cash flow models. In determining the estimated future cash flow, the Company considers and applies certain estimates and judgments, including current and market projected future levels of income based on management’s plans, business trends, prospects and economic conditions and market-participant considerations. If the estimated fair value of the reporting to unit is less than the carrying value, a goodwill impairment loss is recorded for the difference, up the amount of the total goodwill. During the three months ended March 31, 2024, no impairment losses were identified.
Further, the Company recognized a trade name associated with the Bloomia acquisition that was determined to be an indefinite-lived intangible asset. Annually, or if conditions indicate an additional review is necessary, we test indefinite-lived trade names for impairment. We have the option to first assess qualitative factors to determine whether the fair value of a trade name is “more likely than not” less than its carrying value. If it is more likely than not that an impairment has occurred, we then perform the quantitative impairment test. If we perform the quantitative test, the carrying value of the asset is compared to an estimate of its fair value to identify impairment. The fair value is determined by the relief-from-royalty method, which requires significant judgment. Actual results may differ from assumed and estimated amounts utilized in the analysis. If we conclude an impairment exists, the asset's carrying value will be written down to its fair value. During the three months ended March 31, 2024, no impairment losses were identified.
| 9 |
| Table of Contents |
Equity-Method Investments. Investments are accounted for using the equity method of accounting if the investment gives us the ability to exercise significant influence, but not control, over the investee. Under the equity method of accounting, the Company records its investments in equity-method investees in the consolidated balance sheets as equity-method investments and its share of investees’ earnings or losses together with other-than-temporary impairments in value, basis differences between the carrying amount and our ownership interest in the underly net assets of the investee, and any gain or loss from the sale of an equity method investment as gain on sale of equity investment in net income of unconsolidated investments in the statement of operations. The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may be impaired. If a decline in the value of an equity method investment is determined to be other than temporary, a loss is recorded in earnings in the current period.
Investments in equity-method investments and joint ventures of immaterial entities are estimated based upon the overall performance of the entity where financial results are not available on a timely basis.
Fair Value. FASB ASC Topic 820, "Fair Value Measurements and Disclosures," (ASC 820), Fair Value Measurements and Disclosures, establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:
| · | Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date. |
|
|
|
| · | Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. |
|
|
|
| · | Level 3: Significant unobservable inputs that reflect a reporting entity’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. |
The carrying amounts of certain financial instruments, which include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, and other financial working capital items approximate their fair values at March 31, 2024 and December 31, 2023 due to their short-term nature and management’s belief that their carrying amounts approximate the amount for which the assets could be sold or the liabilities could be settled. The carrying amount of debt approximates fair value due to the debt’s variable market interest rate.
Revenue Recognition. The Company accounts for revenue in accordance with FASB Topic 606, “Revenue from Contracts with Customers,” (ASC 606), using the following steps:
| · | Identify the contract or contracts, with a customer; |
| · | Identify the performance obligations in the contract; |
| · | Determine the transaction price; |
| · | Allocate the transaction price to performance obligations in the contract; and |
| · | Recognize revenue when or as the Company satisfies a performance obligation. |
The Company recognizes revenue when obligations under the terms of a contract with its customer are satisfied; this occurs with the transfer of control of its tulips. Revenue is measured as the amount of consideration expected to be received in exchange for transferring products. Revenue from product sales is governed primarily by customer pricing and related purchase orders (“contracts”) which specify shipping terms and the transaction price. Contracts are at standalone pricing. The performance obligation in these contracts is determined by each of the individual purchase orders and the respective stated quantities, with revenue being recognized at a point in time when obligations under the terms of the agreement are satisfied. This generally occurs with the transfer of control of tulips to the customer and the product is delivered.
The Company expenses the incremental costs of obtaining a contract, if the amortization period is one year or less. These costs are included in sales and marketing expense in the Condensed Consolidated Statement of Operations.
| 10 |
| Table of Contents |
The following table presents revenue disaggregated by customer, as determined by the operational nature of their industry:
Period ended March 31 |
| 2024 |
| |
Supermarket |
| $ |
| |
Wholesaler |
|
|
| |
Other |
|
|
| |
Total |
| $ |
| |
For the period ended March 31, 2024, the Company had three customers that account for 10% or more of the total revenues. These three customers accounted for approximately 47%, 13%, and 11%, respectively for the period ended March 31, 2024. As of March 31, 2024, approximately $
Cost of Sales. Cost of sales consists primarily of costs to procure, sort, pick, cool and transport bulbs. Additionally, cost of sales includes labor and facility costs related to production operations.
Shipping and Handling. The Company’s shipping and handling costs include costs incurred with third-party carriers to transport products to customers. The costs of out-bound freight are included in the cost of goods sold in the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss). For the period ended March 31, 2024, the costs of out-bound freight were approximately $
Advertising Costs. The Company expenses advertising costs as incurred. These costs are included within sales, general and administrative expenses in the Condensed Consolidated Statement of Operations and Comprehensive Income (Loss). Total advertising expense was approximately $
Income Taxes. The Company uses the liability method to account for income taxes as prescribed by ASC 740. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities as measured by the enacted tax rates which will be in effect when these differences reverse. Deferred tax expense (benefit) is the result of changes in deferred tax assets and liabilities. Deferred income tax assets and liabilities are adjusted to recognize the effects of changes in tax laws or enacted tax rates in the period during which they are signed into law. In determining the Company’s ability to realize its deferred tax assets, the Company considers any available tax planning strategies that could be implemented. Under ASC 740 a valuation allowance is required when it is more likely than not that all or some portion of the deferred tax assets will not be realized due to the inability to generate sufficient future taxable income of the correct character. Failure to achieve previously forecasted taxable income could affect the ultimate realization of deferred tax assets and could negatively impact the Company’s effective tax rate on future earnings.
The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.
Interest income or expense/penalties attributable to the overpayment or underpayment, respectively, of income taxes is recognized as an element of our provision for income taxes.
As a multinational corporation, we are subject to taxation in many jurisdictions, and the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in various taxing jurisdictions. If we ultimately determine that the payment of these liabilities will be unnecessary, the liability will be reversed, and we will recognize a tax benefit during the period in which it is determined the liability no longer applies. Conversely, the Company records additional tax charges in a period in which it is determined that a recorded tax liability is less than the ultimate assessment is expected to be.
The application of tax laws and regulations is subject to legal and factual interpretation, judgment and uncertainty. Tax laws and regulations themselves are subject to change as a result of changes in fiscal policy, changes in legislation, the evolution of regulations and court rulings. Therefore, the actual liability for U.S. or foreign taxes may be materially different from management’s estimates, which could result in the need to record additional tax liabilities or potentially reverse previously recorded tax liabilities.
| 11 |
| Table of Contents |
Stock Based Compensation. The Company measures and recognizes compensation expense for all stock-based awards at fair value. Restricted stock units and awards are valued at the closing market price of the Company’s stock on the date of the grant. The Company uses the Black-Scholes option pricing model to determine the weighted average fair value of options. The determination of fair value of share-based payment awards on the date of grant using an option-pricing model is affected by our stock price as well as by assumptions regarding several complex and subjective variables. These variables include, but are not limited to, the expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors.
During the three months ended March 31, 2024 and 2023, no stock options or restricted stock were issued by the Company. The Company recorded total stock-based compensation expense of $
Net Income (Loss) per Share. Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average shares outstanding and excludes any dilutive effects of stock options and restricted stock units and awards. Diluted net income (loss) per share gives effect to all diluted potential common shares outstanding during the year.
In determining diluted net income (loss) per share, the Company considers whether the result of the incremental shares would be antidilutive. During the period ended March 31, 2024, the Company was in a net loss position and the result of the potentially dilutive securities was determined to be antidilutive and therefore, no incremental shares are included in any of the per share calculations.
For the period ended March 31, 2024, options to purchase
Weighted average common shares outstanding for the three months ended March 31, 2024 and 2023 were as follows:
| Three months ended March 31 |
| 2024 |
|
| 2023 |
| ||
Denominator for basic net income (loss) per share - weighted average shares |
|
|
|
|
|
| ||
| Effect of dilutive securities: |
|
|
|
|
|
|
|
|
Stock options, restricted stock and restricted stock units |
|
| - |
|
|
| - |
|
Denominator for diluted net income (loss) per share - weighted average shares |
|
|
|
|
|
| ||
3. Bloomia Acquisition
On February 22, 2024, the Company completed the acquisition of a majority interest in Bloomia and its subsidiaries (the “Acquisition”). The Acquisition was completed by the Company through its wholly owned subsidiaries, Tulp 24.1 and Tulipa Acquisitie Holding B.V. (“Tulipa”), pursuant to an Agreement for the Sale and Purchase of Shares by and among Tulp 24.1, Tulipa, Botman Bloembollen B.V., W.F. Jansen (“Jansen”), and H.J. Strengers, and Lendway, as the Guarantor. Jansen will continue to serve as chief executive officer of Bloomia following the Acquisition. As a result of the Acquisition, Tulp 24.1 became the holder of 100% of the ownership interests of Bloomia.
The acquisition has been accounted for in accordance with ASC Topic 805, "Business Combinations", using the acquisition method of accounting. Under the acquisition method of accounting, the total purchase price was allocated to the net identifiable tangible and intangible assets of Bloomia acquired, based on their fair values at the date of the acquisition.
The acquisition was funded through a combination of debt and cash on hand. The total consideration transferred for the Bloomia acquisition was $
| 12 |
| Table of Contents |
Provisional fair value measurements were made for acquired assets and liabilities, and adjustments to those measurements may be made in subsequent periods as information necessary to complete the fair value analysis is obtained. The fair value measurements associated with working capital and the allocation of certain intangible assets are preliminary as of the date these financial statements are available to be issued. We expect to finalize the valuation and complete the purchase price allocation as soon as practicable, but no later than one year from the acquisition date.
The preliminary allocation of the purchase price to assets acquired and liabilities assumed is as follows:
Fair value of purchase consideration |
|
|
| |
Cash consideration |
| $ |
| |
Equity in subsidiary issued (noncontrolling interest) |
|
|
| |
Seller bridge loans |
|
|
| |
Total fair value of consideration |
| $ |
| |
|
|
|
|
|
Fair value of assets acquired and liabilities assumed: |
|
|
|
|
Cash and cash equivalents |
| $ |
| |
Accounts receivable |
|
|
| |
Inventories |
|
|
| |
Prepaid and other |
|
|
| |
Property and equipment |
|
|
| |
Intangible assets |
|
|
| |
Equity method investment |
|
|
| |
Finance lease - right of use assets |
|
|
| |
Operating lease - right of use assets |
|
|
| |
Other assets |
|
|
| |
Total assets acquired |
|
|
| |
|
|
|
|
|
Accounts payable |
|
|
| |
Accrued expenses |
|
|
| |
Finance lease liabilities - current |
|
|
| |
Operating lease liabilities - current |
|
|
| |
Finance lease liabilities - long-term |
|
|
| |
Operating lease liabilities - long-term |
|
|
| |
Deferred tax liabilities |
|
|
| |
Total liabilities assumed |
|
|
| |
Net identifiable assets acquired |
|
|
| |
Goodwill |
|
|
| |
Total consideration transferred |
| $ |
| |
| 13 |
| Table of Contents |
The goodwill recognized is primarily attributable to the growth potential of the Company and is not deductible for tax purposes. The fair value of customer relationships was estimated using a discounted present value income approach. Under the income approach, an intangible asset’s fair value is equal to the present value of future economic benefits to be derived from ownership of the asset. Indications of value are developed by discounting future net cash flows to their present value at market-based rates of return. The fair value of the trade names was estimated using an income approach, specifically known as the relief from royalty method. The relief from royalty method is based on the hypothetical royalty stream that would be received if the Company were to license the trade name and was based on expected revenues. The useful life of the customer relationships was determined considering the period of expected cash flows used to measure the fair value of the intangible assets adjusted as appropriate for the entity-specific factors including legal, regulatory, contractual, competitive, economic or other factors that may limit the useful life of the customer relationships. The issued equity of the subsidiary, now reflected as noncontrolling interest was valued considering the total value of the acquired company and comparing that to the rollover value of the shares being converted.
Revenue, net and net income for Bloomia since the date of acquisition included in the condensed consolidated statement of operations for three months ended March 31, 2024 were approximately $
Unaudited pro forma information has been prepared as if the acquisition had taken place on January 1, 2023. The unaudited pro forma information is not necessarily indicative of the results that we would have achieved had the transaction actually taken place on January 1, 2023, and the unaudited pro forma information does not purport to be indicative of future financial operating results. The unaudited pro forma condensed consolidated financial information does not reflect any operating efficiencies and cost savings that may be realized from the integration of the acquisitions. In accordance with ASC 250-10, the Company is unable to provide unaudited pro forma information for revenue and net earnings for the three months ended March 31, 2023 due to lack of available information during the period prior to ownership. Unaudited pro forma information for the three months ended March 31, 2024 is as follows:
Revenue, net |
| $ |
| |
Net Income |
|
|
|
The Company incurred approximately $
4. Sale of In-Store Marketing Business and Presentation as Discontinued Operations.
On August 3, 2023, the Company completed the sale of certain assets and certain liabilities relating to the Company’s In-Store Marketing Business for a price of $3.5 million to TIMIBO LLC, an affiliate of Park Printing, Inc. (the “Buyer”) under an Asset Purchase Agreement (the “Purchase Agreement”). The Company retained accounts receivable, as well as cash, cash equivalents and marketable securities. The cash consideration for the sale was subject to a post-closing adjustment. The final purchase adjustment for the net balance was to reduce the cash consideration by $
| 14 |
| Table of Contents |
The results of the In-Store Marketing Business have been presented as discontinued operations and the related assets and liabilities have been classified as related to discontinued operations, for all periods presented. The carrying amounts of major classes of assets and liabilities that were reclassified as related to discontinued operations on the Consolidated Balance Sheets were as follows:
|
| March 31, |
|
| December 31, |
| ||
|
| 2024 |
|
| 2023 |
| ||
Current Assets: |
|
|
|
|
|
| ||
Accounts receivable, net |
| $ |
|
| $ |
| ||
Current assets related to discontinued operations |
| $ |
|
| $ |
| ||
|
|
|
|
|
|
|
|
|
Current Liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
| $ |
|
| $ |
| ||
Sales tax |
|
|
|
|
|
| ||
Accrued liabilities |
|
|
|
|
|
| ||
Current liabilities related to discontinued operations |
| $ |
|
| $ |
| ||
Results of discontinued operations are summarized below:
Three Months Ended March 31 |
| 2023 |
| |
Net services revenues |
| $ |
| |
|
|
|
|
|
Cost of services |
|
|
| |
Gross Profit |
|
|
| |
|
|
|
|
|
Operating Expenses: |
|
|
|
|
Selling |
|
|
| |
Marketing |
|
|
| |
General and administrative |
|
|
| |
Total Operating Expenses |
|
|
| |
|
|
|
|
|
Operating Income |
|
|
| |
|
|
|
|
|
Other income |
|
|
| |
Income from discontinued operations before income taxes |
|
|
| |
Income tax benefit |
|
|
| |
Income from discontinued operations, net of tax |
| $ |
| |
The Company collected the remaining accounts receivable from the discontinued operation in April 2024. For the three months ended March 31, 2024, the Company recognized approximately $
5. Inventories.
Inventories at March 31, 2024 consisted of the following:
Finished goods |
| $ |
| |
Work-in-process |
|
|
| |
Raw materials and packaging supplies |
|
|
| |
Total inventories |
| $ |
|
6. Property and Equipment.
Property and equipment at March 31, 2024 consisted of the following:
| Machinery and equipment |
| $ |
| |
| Leasehold improvements |
|
|
| |
| Bushes |
|
|
| |
| Vehicles |
|
|
| |
| Furniture and fixtures |
|
|
| |
| Property and equipment, gross |
|
|
| |
| Less: accumulated depreciation |
|
| ( | ) |
| Property and equipment, net |
| $ |
|
At March 31, 2024, property and equipment, net of $
7. Equity Method Investment.
Araucanía Flowers SA (“Araucania”) is based in Chile and serves as a marketing arm for the Company to export its crops to Latin-America countries. Araucanía has two other shareholders that hold 70% of its aggregate issued and outstanding shares. At March 31, 2024, the Company had a 30% equity interest in Araucania with a carrying amount of approximately $
The Company had a 50% ownership interest in Horti-Group USA LLC (“Horti-Group”). Horti-Group operates a 45-acre facility near Washington D.C. that the Company utilizes to grow and distribute its tulips to North American customers. On February 9, 2023, the Company sold its interest in Horti-Group to V-Maxx for a sale price of $
| 15 |
| Table of Contents |
8. Goodwill and Other Intangible Assets.
The following table summarizes the changes in goodwill:
Balance as of January 1, 2024 |
| $ |
| |
Goodwill resulting from the Bloomia Acquisition |
|
|
| |
Balance as of March 31, 2024 |
| $ |
|
Other intangible assets and related amortization are as follows at March 31, 2024:
|
| Cross Carrying Amount |
|
| Useful Life (Years) |
|
| Accumulated Amortization |
|
| Net Carrying Amount |
| ||||
| Tradename |
| $ |
|
| Indefinite |
|
| $ |
|
| $ |
| ||||
| Customer relationships |
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
| $ |
|
|
|
|
|
| $ |
|
| $ |
| |||
For the three months ended March 31, 2024 amortization of intangible assets expensed to operations was $
Remaining estimated aggregate annual amortization expense is as follows:
Remainder of 2024 |
| $ |
| |
2025 |
|
|
| |
2026 |
|
|
| |
2027 |
|
|
| |
2028 |
|
|
| |
Thereafter |
|
|
| |
Total |
| $ |
|
9. Debt.
The components of debt at March 31, 2024 consisted of the following:
Credit Agreement - term loan |
| $ |
| |
Credit Agreement - revolving credit facility |
|
|
| |
Notes payable |
|
|
| |
|
|
|
| |
|
|
|
|
|
Less: unamortized debt issuance costs |
|
| ( | ) |
|
|
|
|
|
Total debt |
|
|
| |
|
|
|
|
|
Less current maturities |
|
| ( | ) |
|
|
|
|
|
Long term debt, net of current maturities |
| $ |
|
| 16 |
| Table of Contents |
To finance the Bloomia acquisition, the Company entered into a revolving credit and term loan agreement (the “Credit Agreement”), with Tulp 24.1 as the borrower (the “Borrower”) for a $
As part of the financing of the Bloomia acquisition, the Company entered into notes payable with the sellers. Notes payable for $
As of March 31, 2024, there was $
The Company incurred $
Remainder of 2024 |
| $ |
| |
2025 |
|
|
| |
2026 |
|
|
| |
2027 |
|
|
| |
2028 |
|
|
| |
2029 |
|
|
| |
|
| $ |
|
| 17 |
| Table of Contents |
10. Leases.
The Company is party to leasing contracts in which the Company is the lessee. These lease contracts are classified as either operating or finance leases. The Company’s lease contracts include land, buildings, and equipment. Remaining lease terms range from 1 to 15 years with various term extension options available. The Company includes optional extension periods and early termination options in its lease term if it is reasonably likely that the Company will exercise an option to extend or terminate early.
Operating lease ROU assets and operating lease liabilities are recognized based on the present value of lease payments over the lease term, at the later of the commencement date or business combination date. Because most of the Company’s leases do not provide an implicit rate of return, the discount rate is based on the collateralized borrowing rate of the Company, on a portfolio basis.
The balances for operating and finance leases where the Company is the lessee are presented as follows within the condensed consolidated balance sheets:
|
| March 31, |
| |
|
| 2024 |
| |
Operating lease: |
|
|
| |
Operating lease right-of-use assets, net |
| $ |
| |
|
|
|
|
|
Current portion of operating lease obligations |
|
|
| |
Operating lease obligations, net of current portion |
|
|
| |
Total operating lease liabilities |
| $ |
| |
|
|
|
|
|
Finance lease: |
|
|
|
|
Finance lease right-of-use assets, net |
| $ |
| |
|
|
|
|
|
Current portion of finance lease obligations |
|
|
| |
Finance lease obligations, net of current portion |
|
|
| |
Total finance lease liabilities |
| $ |
| |
The Company is party to an operating lease agreement with Horti-Group for land and greenhouses in King George, Virginia, United States. The lease commenced on July 1, 2021 and, including a renewal option the Company expects to exercise, ends on December 31, 2038. The Company recognized the following related party balances in the condensed consolidated balance sheets:
|
| March 31, |
| |
|
| 2024 |
| |
Operating lease right-of-use assets, net |
| $ |
| |
|
|
|
|
|
Current portion of operating lease obligations |
|
|
| |
Operating lease obligations, net of current portion |
|
|
| |
Total operating lease liabilities |
| $ |
| |
| 18 |
| Table of Contents |
The components of lease expense are as follows within our condensed consolidated statements of operations and comprehensive income (loss):
|
| Three Months Ended March 31, |
| |||||
|
| 2024 |
|
| 2023 |
| ||
Operating lease expense: |
|
|
|
|
|
| ||
Operating lease cost |
| $ |
|
| $ |
| ||
Short-term and variable lease cost |
|
|
|
|
|
| ||
Finance lease expense: |
|
|
|
|
|
|
|
|
Amortization of leased assets |
|
|
|
|
|
| ||
Total lease expense |
| $ |
|
| $ |
| ||
The weighted average remaining lease term and weighted average discount rate is as follows:
|
| March 31, |
| |
|
| 2024 |
| |
Weighted average remaining lease term (years) |
|
|
| |
Finance leases |
|
|
| |
Operating leases |
|
|
| |
Weighted average discount rate applied |
|
|
|
|
Finance leases |
|
| % | |
Operating leases |
|
| % | |
Supplemental cash flow information related to leases where the Company is the lessee is as follows:
|
| Three Months Ended March 31, |
| |||||
|
| 2024 |
|
| 2023 |
| ||
Operating cash outflows from operating leases |
| $ |
|
| $ |
| ||
Financing cash outflows from finance leases |
|
|
|
|
|
| ||
Leased assets obtained in excha nge for operating lease liabilities |
|
|
|
|
|
| ||
Leased assets obtained in exchange for finance lease liabilities |
|
|
|
|
|
| ||
As of March 31, 2024, the maturities of the operating and finance lease liabilities are as follows:
|
| Operating |
|
| Finance |
| ||
|
| Leases |
|
| Leases |
| ||
Remainder of 2024 |
| $ |
|
| $ |
| ||
2025 |
|
|
|
|
|
| ||
2026 |
|
|
|
|
|
| ||
2027 |
|
|
|
|
|
| ||
2028 |
|
|
|
|
|
| ||
2029 |
|
|
|
|
|
| ||
Thereafter |
|
|
|
|
|
| ||
Total minimum lease payments |
| $ |
|
| $ |
| ||
Less: imputed interest |
|
| ( | ) |
|
| ( | ) |
Total: present value of lease liabilities |
| $ |
|
| $ |
| ||
Less: current portion |
|
| ( | ) |
|
| ( | ) |
Long-term portion of lease liabilities |
| $ |
|
| $ |
| ||
| 19 |
| Table of Contents |
11. Income Taxes.
For the three months ended March 31, 2024, the Company recorded an income tax benefit of
For the three months ended March 31, 2024, the Company recorded an income tax benefit of $
As of March 31, 2024, and December 31, 2023, the Company had unrecognized tax benefits totaling $
12. Commitments and Contingencies.
Litigation. Liabilities for loss contingencies arising from claims, assessments, litigation, fines, and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred.
In the ordinary course of the business, the Company is subject to periodic legal or administrative proceedings. As of March 31, 2024, the Company was not involved in any material claims or legal actions which, in the opinion of management, the ultimate disposition would have a material adverse effect on the Company’s consolidated financial position, results of operations, or liquidity.
Purchase Obligation. On July 1, 2023
Other than this obligation, the Company has not had any material service or supply agreements that obligate the Company to make payments to vendors for an extended period of time.
As of March 31, 2024, Bloomia had committed to purchase machinery up to a total amount of $
13. Employee Benefit Plans.
The Company sponsors a Retirement Profit Sharing and Savings Plan under Section 401(k) of the Internal Revenue Code. The plan allows employees of Lendway, Inc. to defer up to
For all Dutch employees, the Company participates in defined contribution pension plans with an independent insurance company. Defined contributions are expensed in the year in which the related employee services are rendered. The Company makes contributions on behalf of all Dutch employees of which $
| 20 |
| Table of Contents |
14. Segment Data.
With the Bloomia Acquisition that was completed on February 22, 2024, the Company has two operating and reportable segments: Bloomia and Lending, both of which are described in note 1. The Company's remaining activities are presented as “Corporate“. The Company's Corporate activities consist of corporate transaction expenses, certain corporate fees and expenses, interest expense, and management compensation.
The following table presents summarized financial information concerning the Company’s reportable business segments and Other activities:
| Three months ended March 31, 2024 |
| Bloomia |
|
| Lending |
|
| Corporate |
|
| Total |
| ||||
Revenue, net |
| $ |
|
| $ |
|
| $ |
|
| $ |
| ||||
| Income (loss) from continuing operations before income taxes |
|
|
|
|
| ( | ) |
|
| ( | ) |
|
| ( | ) | |
Total assets |
| $ |
|
| $ |
|
| $ |
|
| $ |
| ||||
| 21 |
| Table of Contents |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in conjunction with the Company’s condensed consolidated financial statements and related notes. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those in such forward-looking statements as a result of many factors, including those discussed in “Cautionary Statement Regarding Forward-Looking Statements” and elsewhere, including Part II, Item 1A, in this Quarterly Report on Form 10-Q and the “Risk Factors” described in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, our Current Reports on Form 8-K and our other SEC filings.
Company Overview
The Company has evolved into a specialty agricultural and finance company focused on making and managing its agricultural investments in the United States and internationally. In 2023 and in the first quarter of 2024, the Company took three major steps in this evolution.
In April 2023, the Company launched its lending business, through the hiring of a Senior Vice President of Lending with over 20 years of experience in credit and lending. The Company is seeking to build a scalable non-bank lending business to purchase existing loans or originate and fund new loans, all of which will be secured by collateral.
On August 3, 2023, the Company completed the sale of its In-Store Marketing Business. The operations of the In-Store Marketing Business are presented as discontinued operations. All prior periods presented have been restated to present the In-Store Marketing Business as discontinued operations.
On February 22, 2024, the Company acquired majority ownership in Bloomia B.V. and its subsidiaries (“Bloomia”). Bloomia produces and sells fresh cut tulips.
As a result of the Bloomia acquisition, the Company has two segments: Bloomia (the “Bloomia Business”) and the Lending Business.
Bloomia Business
Bloomia purchases tulip bulbs, hydroponically grows tulips from the bulbs, and sells the stems to retail stores. Bloomia is a leading producer of fresh cut tulips in the United States, nurturing over 75 million stems annually. Net sales (unaudited) of Bloomia for the twelve months ended December 31, 2023 and 2022 were approximately $45 million and $43 million, respectively. Bloomia was founded in the Netherlands and is now strategically positioned in the United States, Netherlands, South Africa and Chile. Bloomia has relationships with prominent U.S. mass market retailers.
The Company acquired Bloomia for $53,360,000. Consideration comprised of $34,919,000 of cash paid, $15,451,000 of seller bridge loans in lieu of cash, and $2,990,000 of equity issued of Tulp 24.1 which is reflected as noncontrolling interest within these condensed consolidated financial statements. The acquisition was funded through a combination of debt and cash on hand.
| 22 |
| Table of Contents |
Non-Bank Lending Business
While the Company’s primary near-term focus will be on the Bloomia business, the Company plans to continue building a scalable non-bank lending business (our “Lending Business”) to purchase existing loans or originate and fund new loans, all of which will be secured by collateral. Initially, we intend to focus on loans secured by real estate, primarily for agricultural purposes. We expect to expand our product offerings over time as we identify needs and opportunities in the marketplace for loans generally.
The Company met with a number of prospects for loan originations and/or purchases since the start of the lending business. Deals were negotiated, but ultimately did not close. With the Company’s decision to allocate capital to the Bloomia acquisition, capital available for the lending business will be significantly constrained in the near term. Accordingly, we anticipate minimal revenue and operating losses from the lending business during the remainder of 2024.
Summary of Financial Results
The Bloomia Business was acquired on February 22, 2024, from which date, the Bloomia Business had revenue of $8,033,000 through March 31, 2024. The income before taxes of the segment was $1,091,000, which included significant expenses related to the Acquisition. The Bloomia business is highly seasonal with strongest sales months normally from February through May that coincides with Spring in the U.S. and certain holidays. For the periods ended March 31, 2024 and 2023, the Company had revenue from continuing operations of $8,033,000 and $nil, respectively.
The Lending Business had no revenue and had a net loss from continuing operations before income taxes of $325,000. The corporate and other portion of the Company had no revenue and a net loss from continuing operations before income taxes of $2,449,000, which includes significant expenses related to the acquisition.
Adjusted EBITDA from continuing operations for the three months ended March 31, 2024 was $1,745,000.
With the Bloomia acquisition completed on February 22, 2024 for an aggregate purchase price totaling $53,360,000, cash and cash equivalents decreased by $11,064,000 from $16,077,000 at December 31, 2023, to $5,013,000 at March 31, 2024. Working capital decreased $4,335,000 from $15,483,000 at December 31, 2023 to $11,148,000 at March 31, 2024. At March 31, 2024, the Company has total debt under its Credit Agreement and Bridge Loans of $37,425,000.
Results of Operations
The following table sets forth, certain items in our Consolidated Statements of Operations as a percentage of total net sales.
For the Three Months Ended March 31 |
| 2024 |
| |
Revenue, net |
|
| 100.0 | % |
Cost of goods sold |
|
| 76.4 |
|
Gross profit |
|
| 23.6 |
|
Sales, general and administrative |
|
| 42.2 |
|
Operating (loss) income |
|
| (18.6 | ) |
Other income and foreign exchange difference |
|
| (2.4 | ) |
Loss from continuing operations, before tax |
|
| (21.0 | ) |
Income tax benefit (expense) |
|
| 4.3 |
|
Income from discontinued operations, net of tax |
|
| 0.9 |
|
Net (loss) income |
|
| (15.8 | )% |
| 23 |
| Table of Contents |
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
Revenue, Net. Revenue, net for the three months ended March 31, 2024 were $8,033,000, all of which were from Bloomia for the period from its acquisition on February 22, 2024 (“the acquisition date”) through March 31, 2024 (the “acquisition period”). The first and second calendar quarters are normally the strongest sales quarters for Bloomia with the first calendar quarter benefiting from Valentine’s Day, Easter season and the start of the Spring season. The Company added two additional retail customers over the prior period.
Gross Profit. Gross profit for the acquisition period ended March 31, 2024 was $1,894,000 or 23.6% as a percentage of revenue. Gross margin percentage is typically higher in the first and second quarters since sales are typically higher and allow better leverage of fixed costs in costs of sales. For purchase accounting, the inventory was written up to fair value on the acquisition date. This write-up is amortized over the turnover of the inventory and the acquisition period included $1,360,000 of costs related to this amortization.
Operating Expenses
Sales, general and administrative. Sales, general and administrative expenses for the three months ended March 31, 2024 increased 439% to $3,388,000 compared to $628,000 for the three months ended March 31, 2023. The increase was primarily due to $1,542,000 of one-time acquisition related expenses and expanded operations from the acquisition of Bloomia during the acquisition period.
Interest Income and Expense. Interest expense for the three months ended March 31, 2024 was $225,000 compared to interest income of $103,000 for the three months ended March 31, 2023. In connection with the Bloomia acquisition, the Company began incurring interest expenses starting February 21, 2024 which amounted to $352,000 during the acquisition period. The Company has not hedged the risk of its interest expense if the Term SOFR reference rate increases.
Income Taxes. For the three months ended March 31, 2024, the Company recorded an income tax benefit of 20.6% on loss from continuing operations. The rate differs from the federal statutory rate of 21% due to state taxes of 4.7%, valuation allowance change of 17.6% and nondeductible transaction costs and other permanent items of (22.7)%. For the three months ended March 31, 2023, the Company recorded an income tax expense of .2% on loss from continuing operations before income taxes. The rate differs from the federal statutory rate of 21% due to state taxes of 3.5%, valuation allowance change of (22.6)% and other permanent items of (1.7)%.
For the three months ended March 31, 2024, the Company recorded an income tax benefit of $347,000 on the loss from continuing operations before income taxes and equity in net income of equity investment. The overall benefit of $347,000 includes a $451,000 benefit for the reversal of the valuation allowance on federal deferred tax assets. During the quarter the Company established deferred tax liabilities related to the acquisition in the majority ownership of Bloomia. The Company anticipates that the deferred tax liabilities will result in future taxable income that will allow for the realization of the federal deferred tax assets.
As of March 31, 2024, and December 31, 2023, the Company had unrecognized tax benefits totaling $42,000, including interest, which relates to state nexus issues. The amount of the unrecognized tax benefits, if recognized, that would affect the effective income tax rates of future periods is $42,000.
| 24 |
| Table of Contents |
Net Loss from Continuing Operations. For the reasons stated above, net loss from continuing operations for the three months ended March 31, 2024 was $1,336,000, compared to loss of $528,000 for the three months ended March 31, 2023.
Income from Discontinued Operations, Net of Tax. For the three months ended March 31, 2024 the Company recognized approximately $72,000 of benefit in Sales, general and administrative expense of discontinued operations from the reduction in the accrual for sales tax due the expiration of the statute of limitations. Income from discontinued operations, net of tax, was $2,176,000 for the three months ended March 31, 2023, reflecting the normal strong first calendar quarter of the In-store Marketing Business. Information on the sale of the In-Store Marketing Business and statement of operations details of the discontinued operations are included in Note 2 to the Consolidated Financial Statements in Item 8 of our Annual Report on Form 10-K.
Noncontrolling interest. The 18.6% noncontrolling interest in Tulp 24.1’s loss for the acquisition period was $223,000.
Net Loss. For the reasons stated above, the net loss for the three months ended March 31, 2024 was $1,264,000, compared to net income of $1,648,000 for the three months ending March 31, 2023. As discussed in the sales section, we anticipate seasonality in sales, with sales being lower in the last half of the year, resulting in an expected loss for the full year because of one-time acquisition cost and amortization expense.
Non-GAAP Financial Measures
This report includes EBITDA and Adjusted EBITDA, each of which is a “non-GAAP financial measure.” EBITDA is defined as net income before interest expense, provision for income taxes, and depreciation and amortization expense. Adjusted EBITDA is defined as EBITDA after additional pretax adjustments.
These non-GAAP financial measures, which are not calculated or presented in accordance with U.S. generally accepted accounting principles (“GAAP”), have been provided as information supplemental and in addition to the financial measures presented in accordance with GAAP. Such non-GAAP financial measures are not substitutes for, or as an alternative to, and should be considered in conjunction with, respective GAAP financial measures. The non-GAAP financial measures presented may differ from similarly named measures used by other companies.
Included below are reconciliations of EBITDA and Adjusted EBITDA to net loss from continuing operations, the most directly comparable GAAP measure. We have included these non-GAAP performance measures as a comparable measure to eliminate the effects of non-recurring transactions that occurred during the three months ended March 31, 2024. We believe Adjusted EBITDA provides meaningful supplemental information about our operating performance as this measure excludes amounts from net loss from continuing operations that we do not consider part of our core operating results when assessing our performance. Items excluded from Adjusted EBITDA consist of acquisition-related costs and other costs such as the cost of inventory that was stepped up to fair value as a result of the purchase accounting related to our acquisition of a majority interest in Bloomia. Adjusted EBITDA does not reflect our cash expenditures, the cash requirements for the replacement of depreciated and amortized assets, or changes in or cash requirements for our working capital needs.
We believe these non-GAAP financial measures will be useful to permit investors to compare results with prior periods that did not include the one-time events and the resulting accounting charges. Management has used EBITDA and Adjusted EBITDA (a) to evaluate our historical and prospective financial performance and trends as well as our performance relative to competitors and peers; (b) to measure operational profitability on a consistent basis; (c) in presentations to the members of our Board of Directors; and (d) to evaluate compliance with covenants and restricted activities under the terms of our Credit Agreement and outstanding notes, as further described in the Notes to Consolidated Financial Statements included in Item 1 of Part I of this report.
| 25 |
| Table of Contents |
Reconciliation of Net Loss from Continuing Operations
to EBITDA and Adjusted EBITDA from continuing operations
| Three months ended March 31, |
| 2024 |
|
| 2023 |
| ||
Net loss from continuing operations |
| $ | (1,336,000 | ) |
| $ | (528,000 | ) |
Interest (income) expense, net |
|
| 225,000 |
|
|
| (103,000 | ) |
Provision for income taxes |
|
| (347,000 | ) |
|
| 3,000 |
|
Depreciation and amortization |
|
| 300,000 |
|
|
| 14,000 |
|
EBITDA |
|
| (1,158,000 | ) |
|
| (614,000 | ) |
Acquistion-related costs |
|
| 1,542,000 |
|
|
| - |
|
| Non-operating (income) loss (1) |
|
| 1,361,000 |
|
|
| - |
|
| Adjusted EBITDA |
| $ | 1,745,000 |
|
| $ | (614,000 | ) |
(1) For the three months ended March 31, 2024, Other was related to (i) $1,360,000 in cost of products for cost of inventory that was stepped up to fair value during purchase accounting related to the Bloomia acquisition and (ii) $1,000 of stock-based compensation expense.
SEGMENT RESULTS OF OPERATIONS
The summary that follows provides a discussion of the results of operations of our two reportable segments (Bloomia and Lending).
We evaluate performance based on net sales and segment income and use a variety of ratios to measure performance of our reporting segments. Segment income represents operating income from continuing operations before income taxes exclusive of intangible amortization, certain acquisition related expenses and other unusual non-operating items.
Bloomia Business
The net sales, segment income, and total assets for Bloomia were as follows:
| Three months ended March 31, 2024 |
| Bloomia |
| |
Revenue, net |
| $ | 8,033,000 |
|
| Income (loss) from continuing operations before income taxes |
|
| 1,091,000 |
|
Total assets |
| $ | 102,981,000 |
|
The first and second calendar quarters historically have been the strongest sales quarters for Bloomia with Valentine’s Day, the Easter season and the start of the Spring season.
Lending Business
| Three months ended March 31, 2024 |
| Lending |
| |
Revenue, net |
| $ | - |
|
| Income (loss) from continuing operations before income taxes |
|
| (325,000 | ) |
Total assets |
| $ | 2,049,000 |
|
| 26 |
| Table of Contents |
With the focus on the Bloomia acquisition during the three months ended March 31, 2024, there was no revenue, and marketing efforts and related expense were reduced.
Corporate
| Three months ended March 31, 2024 |
| Corporate |
| |
Revenue, net |
| $ | - |
|
| Income (loss) from continuing operations before income taxes |
|
| (2,449,000 | ) |
Total assets |
| $ | 1,794,000 |
|
Corporate consists of corporate transaction expenses, certain corporate fees and expenses, interest expense, and certain executive management compensation.
Liquidity and Capital Resources
The Company has financed its operations with proceeds from stock sales and sales of its services and products, in addition to a significant payment resulting from the settlement of litigation. To aid in funding the Bloomia acquisition, Tulp 24.1 entered a Credit Agreement that provided an $18,000,000 term loan and a revolver with borrowings of up to $6,000,000. At March 31, 2024, the Company’s working capital (defined as current assets less current liabilities) was $11,148,000 compared to $15,483,000 at December 31, 2023. During the three months ended March 31, 2024 cash and cash equivalents decreased $11,064,000 from $16,077,000 at December 31, 2023 to $5,013,000 at March 31, 2024.
Operating Activities. Net cash provided by operating activities during the three months ended March 31, 2024 was $1,470,000, of which $86,000 was provided by operating activities of discontinued operations. Net loss of $1,264,000 plus non-cash adjustments of $456,000 reduced by adjustments for deferred income tax benefits of $505,000, was more than offset by changes in operating assets and liabilities of $2,697,000 which resulted in the $1,470,000 of cash provided by operating activities. The non-cash adjustments consisted of depreciation expense, changes in allowance for doubtful accounts, stock-based compensation expense, and non-cash operating lease expense as well as adjustments for deferred tax benefits recorded in net income. The largest component of the change in operating assets and liabilities was inventories which decreased $3,322,000 from the balance acquired from Bloomia, resulting in an equivalent amount added back to net income to calculate net cash provided by operating activities.
Investing Activities. Net cash used in investing activities during the three months ended March 31, 2024 was $34,372,000, which primarily related to the purchase price and other expenses resulting from the acquisition of Bloomia. Net cash used in investing activities also includes cash paid for purchases of property and equipment.
Financing Activities. Net cash provided by financing activities during the three months ended March 31, 2024 was $21,835,000, which primarily related to proceeds received from issuance of the Credit Agreement used to fund the acquisition of a majority interest in Bloomia.
On February 22, 2024, the Company acquired majority ownership in Bloomia for a total purchase price of $53,360,000. Consideration comprised of $34,919,000 of cash paid, $15,451,000 of seller bridge loans in lieu of cash, and $2,990,000 of equity issued of Tulp 24.1 which is reflected as noncontrolling interest within these condensed consolidated financial statements. The acquisition was funded through a combination of debt and cash on hand. The Company expects that the new credit facility will provide sufficient credit availability to support its ongoing operations, fund its new debt service requirements, capital expenditures and working capital for at least the next 12 months.
To finance the Bloomia acquisition, the Company entered into the Credit Agreement, together with Tulp 24.1 as the borrower. Under the terms of the Credit Agreement, Tulp 24.1 had an $18.0 million term loan funded. The Credit Agreement also contains a $6.0 million revolving credit facility, which may be used by Tulp 24.1 for general business purposes and working capital.
| 27 |
| Table of Contents |
Borrowings under the Credit Agreement bear interest at a rate per annum equal to Term SOFR for an interest period of one month plus 3.0%. In addition to paying interest on the outstanding principal under the Credit Agreement, Tulp 24.1 is required to pay a commitment fee of 0.50% on the unutilized commitments under the revolving credit facility.
The term loans are scheduled to be repaid in quarterly installments of $450,000, commencing on June 30, 2024. The remaining outstanding balance will be repaid in full after five years. The scheduled maturity of the revolving facility is February 20, 2029.
The obligations under the Credit Agreement are secured by substantially all of the personal property assets of Tulp 24.1 and its subsidiaries. The Company provided an unsecured guaranty of the obligations of Tulp 24.1 under the Credit Agreement.
Commencing with the fiscal quarter ending on March 31, 2024, the Credit Agreement will require Tulp 24.1 and its subsidiaries to maintain (a) a minimum fixed charge coverage ratio of not less than 1.25 to 1.00 and (b) a maximum senior cash flow leverage ratio of 3.0 to 1.0 until September 30, 2024, and stepping down to 2.00 to 1.00 on December 31, 2027, until the maturity date of the Credit Agreement. The Credit Agreement also contains other customary affirmative and negative covenants, including covenants that restrict the ability of Tulp 24.1 and its subsidiaries to incur additional indebtedness, dispose of significant assets, make distributions or pay dividends to the Company, make certain investments, including any acquisitions other than permitted acquisitions, make certain payments, enter into sale and leaseback transactions or grant liens on its assets, subject to certain limitations.
The Credit Agreement contains customary events of default, the occurrence of which would permit the lenders to terminate their commitments and accelerate loans under the Credit Agreement, including failure to make payments under the credit facility, failure to comply with covenants in the Credit Agreement and other loan documents, cross default to other material indebtedness of Tulp 24.1 or any of its subsidiaries, failure of Tulp 24.1 or any of its subsidiaries to pay or discharge material judgments, bankruptcy of Tulp 24.1 or any of its subsidiaries, and change of control of the Company.
As of March 31, 2024, the Company was in compliance with these financial covenants, and expects to be in compliance for at least the next twelve months.
As part of the financing of the Bloomia acquisition, Tulp 24.1 entered into notes payable with the sellers. Notes payable for $12.8 million have a term of five years, subject to requiring principal payments based on “excess cash flow” as defined. Interest is at 8% per annum in the first year and increases annually by 2 percentage points. Notes payable for $2.7 million have a term of nine calendar weeks after the closing date. Interest is at 8% per annum.
The notes payable for $2.7 million were paid in full after the end of the quarter, in April 2024.
As the Company grows its businesses, we may be required to obtain additional capital through equity offerings or additional debt financings. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our stockholders will be diluted, and the terms of those securities may include liquidation or other preferences that adversely affect the rights of our stockholders. Debt financing and preferred equity financing, if available, may involve agreements that include additional covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. Additional capital may not be available when needed, on reasonable terms, or at all, and our ability to raise additional capital may be adversely impacted by potential worsening global economic conditions and the recent disruptions to and volatility in the credit and financial markets in the U.S. and worldwide. If we are unable to raise additional funds when needed we may not be able to grow our businesses, or complete transactions related to the strategy.
Critical Accounting Estimates
Our discussion of our financial condition and results of operations is based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. During the preparation of these financial statements, we are required to make estimates and assumptions that affect the reported amounts of assets, liabilities, net sales, costs and expenses and related disclosures. On an ongoing basis, we evaluate our estimates and assumptions, including those related to business combinations, inventory, goodwill, long-lived and indefinite-lived assets, and income taxes. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. The results of our analysis form the basis for making assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions, and the impact of such differences may be material to our financial statements.
| 28 |
| Table of Contents |
Our significant accounting policies are described in Note 2 to the financial statements included in Part I, Item 1 of this report. We believe our most critical accounting estimates include the following:
Inventory. We coordinate with recurring customers to plan production based on anticipated demand and projections; however, we may have to write down inventory or recognize a material impairment if our production significantly exceeds customer demand.
Business Combinations. We account for business combinations under the acquisition method of accounting. This method requires the recording of acquired assets, including separately identifiable intangible assets, and assumed liabilities at their acquisition date fair values. The excess of the purchase price over the fair value of assets acquired and liabilities assumed is recorded as goodwill. Determining the fair value of assets acquired and liabilities assumed requires management’s judgment and often involves the use of significant estimates and assumptions, including assumptions with respect to future cash inflows and outflows, discount rates, royalty rates and asset lives, among other items.
We used the income approach to value certain intangible assets. Under the income approach, an intangible asset’s fair value is equal to the present value of future economic benefits to be derived from ownership of the asset. The fair value of customer relationships was estimated using a discounted present value income approach. We used the income approach known as the relief from royalty method to value the fair value of the trade name. The relief from royalty method is based on the hypothetical royalty stream that would be received if we were to license the trade name and was based on expected revenues. The determination of the fair value of other assets acquired and liabilities assumed involves assessing factors such as the expected future cash flows associated with individual assets and liabilities and appropriate discount rates at the date of the acquisition.
Allocations of the purchase price for acquisitions are based on estimates of the fair value of the net assets acquired and are subject to adjustment upon finalization of the purchase price allocation. During this measurement period, we will adjust assets or liabilities if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of those assets and liabilities as of that date. All changes that do not qualify as measurement period adjustments are included in current period earnings.
If the actual results differ from the estimates and judgments used in these fair values, the amounts recorded in the consolidated financial statements could result in a possible impairment of the intangible assets and goodwill or require acceleration of the amortization expense of finite-lived intangible assets.
Impairment of goodwill and indefinite-lived intangibles. Goodwill represents the excess of the cost of acquired businesses over the net of the fair value of identifiable tangible net assets and identifiable intangible assets purchased and liabilities assumed.
We test goodwill and identifiable intangible assets with indefinite lives for impairment at least annually in the fourth quarter. Impairment testing for goodwill is done at a reporting unit level and all goodwill is assigned to a reporting unit. Our reporting units are the same as our reporting segments.
We test goodwill for impairment by either performing a qualitative evaluation or a quantitative test, whereby a goodwill impairment loss will be measured as the excess of a reporting unit's carrying amount over its fair value. The qualitative evaluation is an assessment of factors, including reporting unit specific operating results and cost factors, as well as industry, market and general economic conditions, to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. We may elect to bypass this qualitative assessment and perform the quantitative test in accordance with ASC 350, Intangibles - Goodwill and Other. Fair values under the quantitative test are estimated using a combination of discounted projected future earnings or cash flow methods and multiples of earnings in estimating fair value. The estimate of the reporting unit’s fair value is determined by weighting a discounted cash flow model and a market-related model using current industry information that involve significant unobservable inputs (Level 3 inputs). In determining the estimated future cash flow, we consider and apply certain estimates and judgments, including current and projected future levels of income based on management’s plans, business trends, prospects and market and economic conditions and market-participant considerations. These assumptions require significant judgment and actual results may differ from assumed and estimated amounts.
| 29 |
| Table of Contents |
If we fail the quantitative assessment of goodwill impairment ("quantitative assessment"), we would be required to recognize an impairment loss equal to the amount that a reporting unit's carrying value exceeded its fair value.
We have an indefinite-lived intangible asset for trade name of $8,570,000 from the Bloomia acquisition. Annually in the fourth quarter, or if conditions indicate an additional review is necessary, we assess qualitative factors to determine if it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. We have the option to first assess qualitative factors to determine whether the fair value of a trade name is “more likely than not” less than its carrying value. If it is more likely than not that an impairment has occurred, we then perform the quantitative impairment test. If we perform the quantitative test, the carrying value of the asset is compared to an estimate of its fair value to identify impairment. The fair value is determined by the relief-from-royalty method, which requires significant judgment. Actual results may differ from assumed and estimated amounts utilized in the analysis. If we conclude an impairment exists, the asset's carrying value will be written down to its fair value.
Long-Lived Assets. Long-lived assets, which include property and equipment, and definite-lived intangible assets, primarily customer relationships and trade name, are assessed for impairment whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. The impairment testing involves comparing the carrying amount of the asset to the forecasted undiscounted future cash flows generated by that asset. These assumptions require significant judgment and actual results may differ from assumed and estimated amounts. In the event the carrying amount of the asset exceeds the undiscounted future cash flows generated by that asset and the carrying amount is not considered recoverable, an impairment exists. An impairment loss is measured as the excess of the asset’s carrying amount over its fair value and is recognized in the statement of income in the period that the impairment occurs. The reasonableness of the useful lives of this asset and other long-lived assets is regularly evaluated.
Income taxes. Deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws. Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which it operates, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax-planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the “more likely than not” criteria.
The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.
As a multinational corporation, we are subject to taxation in many jurisdictions, and the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in various taxing jurisdictions. If we ultimately determine that the payment of these liabilities will be unnecessary, the liability will be reversed, and we will recognize a tax benefit during the period in which it is determined the liability no longer applies. Conversely, the Company records additional tax charges in a period in which it is determined that a recorded tax liability is less than the ultimate assessment is expected to be.
The application of tax laws and regulations is subject to legal and factual interpretation, judgment and uncertainty. Tax laws and regulations themselves are subject to change as a result of changes in fiscal policy, changes in legislation, the evolution of regulations and court rulings. Therefore, the actual liability for U.S. or foreign taxes may be materially different from management’s estimates, which could result in the need to record additional tax liabilities or potentially reverse previously recorded tax liabilities.
| 30 |
| Table of Contents |
Cautionary Statement Regarding Forward-Looking Statements
Certain statements made in this report that are not statements of historical or current facts are “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results or performance of the Company to be materially different from the results or performance expressed or implied by such forward-looking statements. The words “anticipate,” “believe,” “could,” “estimate,” “expect,” “future,” “intend,” “likely,” “may,” “plan,” “project,” “will” and similar expressions identify forward-looking statements. Forward-looking statements include statements expressing the intent, belief or current expectations of the Company and members of our management team regarding, for instance: (i) our belief that our cash balance, cash generated by operations and borrowings available under our Credit Agreement, will provide adequate liquidity and capital resources for at least the next twelve months, and (ii) regarding the potential for growth and other opportunities for our businesses. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. These statements are subject to the risks and uncertainties that could cause actual results to differ materially and adversely from the forward-looking statements. These forward-looking statements are based on current information, which we have assessed and which by its nature is dynamic and subject to rapid and even abrupt changes.
Factors that could cause our estimates and assumptions as to future performance, and our actual results, to differ materially include the following: (1) our ability to integrate and continue to successfully operate the newly acquired Bloomia business, (2) our ability to compete, (3) concentration of Bloomia’s historical revenue among a small number of customers, (4) changes in interest rates, (5) ability to comply with the requirements of the Credit Agreement, (6) the limited history of our Lending Business, (7) the substantial risk of loss associated with lending generally, (8) market conditions that may restrict or delay appropriate or desirable opportunities, (9) our ability to develop and maintain necessary processes and controls relating to our businesses (10) reliance on one or a small number of employees in each of our businesses, (11) potential adverse classifications of our Company if we are unsuccessful in executing our business plans, (12) other economic, business, market, financial, competitive and/or regulatory factors affecting the Company’s businesses generally; (13) our ability to attract and retain highly qualified managerial, operational and sales personnel; and (14) the availability of additional capital on desirable terms, if at all. Forward-looking statements involve known and unknown risks, uncertainties and other factors, including those set forth in this report and additional risks, if any, identified in this Form 10-K, our Quarterly Reports on Form 10-Q, and our Current Reports on Form 8-K filed with the SEC. Such forward-looking statements should be read in conjunction with the Company’s filings with the SEC. Lendway assumes no responsibility to update the forward-looking statements contained in this report or the reasons why actual results would differ from those anticipated in any such forward-looking statement, other than as required by law.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
As a smaller reporting company, we are not required to provide disclosure pursuant to this item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) that are designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and (ii) accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
The Company’s management carried out an evaluation, under the supervision and with the participation of the Company’s principal executive officer and principal financial officer and its principal accounting officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report, pursuant to Exchange Act Rule 13a-15. Based upon that evaluation, Randy Uglem, principal executive officer and Zackery Weber, principal accounting and financial officer concluded that the Company’s disclosure controls and procedures as of March 31, 2024 were effective.
Changes in Internal Control Over Financial Reporting
During the first quarter of 2024, we completed the acquisition of a majority interest in Bloomia B.V. (“Bloomia”) which represents a material change in internal control over financial reporting since management's last assessment. Prior to the acquisition, Bloomia was a private company and has not been subject to the Sarbanes-Oxley Act of 2002, the rules and regulations of the SEC, or other corporate governance requirements to which public reporting companies may be subject. As part of our ongoing integration activities, we are continuing to incorporate our controls and procedures into the acquired Bloomia subsidiaries and to augment our company-wide controls to reflect the risks inherent in an acquisition of this type.
Other than the Bloomia acquisition, there were no changes in the Company’s internal control over financial reporting occurred during the first quarter of 2024 that have materially affected, or are reasonable likely to materially affect, the Company’s internal control over financial reporting.
| 31 |
| Table of Contents |
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
A description of our legal proceedings, if any, is contained in Note 12 of the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q, incorporated herein by reference.
Item 1A. Risk Factors
There have been no material changes in our risk factors from those previously disclosed in of Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Share Repurchases
On August 28, 2023, we announced that our Board of Directors had approved a stock repurchase authorization providing for the repurchase of up to 400,000 shares of the Company’s common stock. We may purchase shares of our common stock from time to time in open market transactions at prevailing market prices, in privately negotiated transaction, or by other means in accordance with federal securities laws. Open market repurchases may be effected pursuant to Rule 10b5-1 trading plans. The repurchase authorization does not obligate the Company to acquire any particular amount of its common stock or to acquire shares on any particular timetable and may be suspended or discontinued at any time at the Company’s discretion. There was no repurchase activity for the three months ended March 31, 2024.
Item 3. Defaults upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
During the three months ended March 31, 2024, no director or officer of the Company
| 32 |
| Table of Contents |
Item 6. Exhibits
Exhibit Number |
|
Description |
|
Incorporated by Reference To |
|
|
|
|
|
| Exhibit 2.1 to Current Report filed May 25, 2023 | |||
|
|
|
|
|
| Exhibit 2.1 to Current Report filed February 26, 2024 | |||
|
|
|
|
|
| Exhibit 3.1 to Current Report filed August 9, 2023 | |||
|
|
|
|
|
| Exhibit 3.2 to Current Report filed August 9, 2023 | |||
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
| ||
|
|
|
|
|
| Exhibit 10.1 to Form 8-K filed February 26, 2024 | |||
|
|
|
|
|
| Exhibit 10.2 to Form 8-K filed February 26, 2024 | |||
|
|
|
|
|
| Exhibit 10.3 to Form 8-K filed February 26, 2024 | |||
|
|
|
|
|
| Exhibit 10.4 to Form 8-K filed February 26, 2024 | |||
|
|
|
|
|
| Exhibit 10.5 to Form 8-K filed February 26, 2024 | |||
|
|
|
|
|
| Exhibit 10.6 to Form 8-K filed February 26, 2024 | |||
|
|
|
|
|
|
| Filed Electronically | ||
|
|
|
|
|
|
| Filed Electronically | ||
|
|
|
|
|
|
| Furnished Electronically | ||
|
|
|
|
|
101 |
| The following materials from Lendway, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, formatted in inline XBRL (extensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets; (ii) Condensed Consolidated Statements of Operations and Comprehensive Income (Loss); (iii) Condensed Consolidated Statements of Stockholders’ Equity; (iv) Condensed Consolidated Statements of Cash Flows; and (v) Notes to Condensed Consolidated Financial Statements |
| Filed Electronically |
|
|
|
|
|
104 |
| Cover Page Interactive Data File (the cover page XBRL tags are embedded in the inline XBRL document) |
| Filed Electronically |
* Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule will be furnished to the SEC upon request; provided, however, that the parties may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any document so furnished.
** Denotes a management contract or compensatory plan or arrangement required to be filed as an exhibit to this report pursuant to Item 15(b) of Form 10-K.
| 33 |
| Table of Contents |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| LENDWAY, INC. |
|
| (Registrant) |
|
|
|
|
Dated: May 21, 2024 | /s/ Randy D. Uglem |
|
| Randy D. Uglem |
|
| President and Chief Executive Officer |
|
| (on behalf of registrant) |
|
|
|
|
Dated: May 21, 2024 | /s/ Zackery A. Weber |
|
| Zackery A. Weber |
|
| Vice President of Finance |
|
| (principal financial and accounting officer) |
|
| 34 |
EXHIBIT 10.1
EXECUTION VERSION
PRIVILEGED & CONFIDENTIAL
EMPLOYMENT AGREEMENT
This Employment Agreement (“Agreement”) is made effective as of February 20, 2024 (“Effective Date”) by and between Fresh Tulips USA, LLC, a Virginia limited liability company (together with any Affiliate (as defined below) of Fresh Tulips USA, LLC, the “Company”), and Werner Frank Jansen (“Employee”) (collectively “Parties” or individually “Party”).
RECITALS
WHEREAS, reference is hereby made to that certain agreement for sale and purchase of shares in the share capital of Bloomia B.V. (the “Parent”), by and among Botman Bloembollen B.V., Employee and Mr. H.J. Strengers (“Sellers”), Tulipa Acquisitie Holding B.V. (“Purchaser”), and Tulp 24.1, LLC (“US Purchaser”), pursuant to which Purchaser will acquire all issued and outstanding shares in the share capital of the Parent held by Botman Bloembollen B.V. and Mr. H.J. Strengers, and US Purchaser will acquire all issued and outstanding shares in the share capital of the Parent held by Employee (the “Transaction”);
WHEREAS, the Company is a wholly-owned subsidiary of the Parent;
WHEREAS, pursuant to the terms and conditions of the Purchase Agreement, Employee’s and the Parent’s execution of this Agreement are conditions to the consummation of the Transaction;
WHEREAS, Employee has been employed by the Company pursuant to an employment contract dated July 2, 2020, as subsequently amended in writing July 1, 2022 (the “Prior Employment Agreement”);
WHEREAS, the Company and Employee are parties to a Performance Bonus Plan Agreement dated July 2, 2020, as subsequently amended in writing July 1, 2022, February 16, 2023, and January 24, 2024 (the “Bonus Agreement”);
WHEREAS, the Company desires to continue to employ Employee, and Employee desires to continue to be employed by the Company;
WHEREAS, on February 20, 2024, the Company provided to Employee letter that memorializes the terms of Employee’s cash incentive compensation as an employee of the Company for the Company’s fiscal year ending December 31, 2024 (the “2024 Bonus Plan”);
WHEREAS, the Company and Employee desire to enter into this Agreement, which together with the 2024 Bonus Plan will supersede and replace the Prior Employment Agreement and the Bonus Agreement in their entirety, and the Company and Employee intend that this Agreement and the 2024 Bonus Plan will govern the terms of Employee’s employment with the Company after the Effective Date;
WHEREAS, Employee has been employed by the Company, and will continue to be employed by the Company, in a position of trust and confidence, and has had access to, and will continue to have access to, proprietary confidential and/or trade secret information of the Company;
WHEREAS, Employee acknowledges that the Company has expended substantial time and resources to develop proprietary confidential and/or trade secret information and to develop valuable relationships and goodwill within its industry;
WHEREAS, Employee acknowledges that the Company operates in a highly competitive environment and the importance to the Company of ensuring the Employee’s loyalty and protection of the Company’s actual and prospective customers, business relations, employees, and confidential information.
| 1 |
NOW, THEREFORE, in consideration of the continued employment of Employee by the Company, and further in consideration of the salary, wages or other compensation and benefits to be provided by the Company to Employee, which Employee acknowledges and agrees includes a base salary increase, and for additional mutual covenants and conditions, the receipt and sufficiency of which are hereby acknowledged, the Company and Employee, intending legally to be bound, hereby agree as follows:
AGREEMENT
In consideration of the above recitals and the mutual promises set forth in this Agreement, the Parties agree as follows:
1. Nature and Capacity of Employment.
1.1 Title and Duties. Effective as of Effective Date, the Company will employ Employee as its Chief Executive Officer, pursuant to the terms and conditions set forth in this Agreement. Employee will report to Chief Executive Officer of Lendway, Inc. and shall perform such duties and responsibilities for the Company (including any Affiliate) as assigned to Employee from time to time consistent with Employee’s position. “Affiliate” means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trustee or trust, a joint venture, or an unincorporated organization, that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, Fresh Tulips USA, LLC, including without limitation the Parent, Purchaser and US Purchaser. Employee shall serve the Company faithfully and to the best of Employee’s ability and shall at all times act in accordance with the law. Employee shall devote Employee’s full working time, attention and efforts to performing Employee’s duties and responsibilities under this Agreement and advancing the Company’s business interests. Employee shall follow applicable policies and procedures adopted by the Company from time to time, including those relating to business ethics, conflict of interest and non-discrimination. Employee shall not, without the prior written consent of the Company, accept other employment or engage in other business activities during Employee’s employment with the Company that may prevent Employee from fulfilling the duties or responsibilities as set forth in or contemplated by this Agreement. Employee may, however, manage personal and family investments and affairs, participate in industry organizations and deliver lectures at educational institutions, so long as such activities do not interfere with the performance of Employee’s responsibilities hereunder.
1.2 Location. Employee’s employment will be based at the Company’s headquarters in Virginia. Employee acknowledges and agrees that Employee’s position, duties and responsibilities will some regular travel, both in the U.S. and internationally.
2. Term. Unless terminated at an earlier date in accordance with Section 8, the term of Employee’s employment with the Company under the terms and conditions of this Agreement will be for the period commencing on the Effective Date and ending on the two (2) year anniversary of the Effective Date (the “Initial Term”). On the two (2) year anniversary of the Effective Date, and on each succeeding one-year anniversary of the Effective Date (each an “Anniversary Date”), the Term shall be automatically extended until the next Anniversary Date (each a “Renewal Term”), subject to termination on an earlier date in accordance with Section 8 or unless either Party gives written notice of non-renewal to the other Party at least ninety (90) days prior to the Anniversary Date on which this Agreement would otherwise be automatically extended that the Party providing such notice elects not to extend the Term. The Initial Term together with any Renewal Terms is the “Term.” If Employee remains employed by the Company after the Term ends for any reason, then such continued employment shall be according to the terms and conditions established by the Company from time to time (provided that any provisions of this Agreement that by their terms survive the termination of the Term shall remain in full force and effect).
| 2 |
3. Compensation, Benefits and Business Expenses.
3.1 Base Salary. As of the Effective Date, the Company agrees to pay Employee an annualized base salary of $300,000.00 (hereinafter referred to as the “Base Salary”). The Base Salary will be earned by Employee on a pro rata basis as Employee performs services and shall be paid according to the Company’s normal payroll practices.
3.2 Annual Incentive Bonus. While Employee is employed by the Company, Employee will be eligible to participate in such annual incentive compensation program as may be approved, amended or replaced from time to time by the Company and for which Employee meets the eligibility criteria, subject to the terms and conditions of any such program, including measuring Employee’s performance against metrics established by the Company. For calendar year 2024, Employee’s target bonus shall equal fifty percent (50%) of Employee’s annualized Base Salary for 2024, and Employee will be eligible to earn an additional growth bonus pursuant to the terms and conditions of Employee’s 2024 annual bonus plan as established by the Company in the 2024 Bonus Plan.
3.3 Employee Benefits. While Employee is employed by the Company during the
Term, Employee shall be entitled to participate in the retirement plans, equity compensation plans, health plans, and all other employee benefits made available by the Company, and as they may be changed from time to time. Employee acknowledges and agrees that Employee will be subject to all eligibility requirements and all other provisions of these benefits plans, and that the Company is under no obligation to Employee to establish and maintain any employee benefit plan in which Employee may participate.
3.4 Paid Time Off. While Employee is employed by the Company during the Term, Employee shall be eligible for up to 28 days of paid time off per calendar year in accordance with the Company’s policies then in effect. Paid time off may be used for illness or other personal business, or as vacation time off at such times so as not to materially disrupt the operations of the Company, or as required under applicable law.
3.5 Business Expenses. While Employee is employed by the Company during the Term, the Company shall reimburse Employee for all reasonable and necessary out-of-pocket business, travel, and entertainment expenses incurred by Employee in the performance of Employee’s duties and responsibilities hereunder, subject to the Company’s normal policies and procedures for expense verification and documentation.
4. Protection of Confidential Information.
4.1 Definition of Confidential Information. As used in this Agreement, the term “Confidential Information” shall mean any information which the Employee has learned or developed, or learns or develops, during the Employee’s employment with the Company (including during any period of Employee’s employment with the Company prior to the Effective Date) that derives independent economic value from being not generally known or readily ascertainable by other persons who could obtain economic value from its disclosure or use, and includes, but is not limited to, trade secrets, financial information, personnel information, and information relating to such matters as existing or contemplated products, services, profit margins, fee schedules, pricing, design, processes, formulae, business plans, sales techniques, marketing techniques, training manuals and materials, policies or practices related to the Company’s business, personnel or other matters, computer databases, computer programs, software and other technology, customer lists and requirements, vendor lists, or supply information. Confidential Information includes such information of the Company, its customers, vendors, and other third parties or entities with whom the Company does business. Any information disclosed to the Employee or to which the Employee has had access to or has access to during the time of the Employee’s employment (including during any period of Employee’s employment with the Company prior to the Effective Date) that the Employee reasonably considers to be Confidential Information, or which the Company treats as Confidential Information, will be presumed Confidential Information.
| 3 |
4.2 Restrictions on Use or Disclosure of Confidential Information. The Employee shall keep the Confidential Information in absolute confidence both during the Employee’s employment with the Company and after the termination of the Employee’s employment, regardless of the reason for such termination. The Employee agrees that the Employee has not and will not, at any time, disclose to others, use for the benefit of any entity or person other than the Company, or otherwise take or copy any such Confidential Information, whether or not developed by the Employee, except as required in the Employee’s duties to the Company.
4.3 Exceptions. The confidentiality and restriction on the use of Confidential Information under this Agreement shall not apply to Confidential Information to the extent that such Confidential Information: is now, or hereafter becomes, through no breach of this Agreement by the Employee, generally known or available to the public; was known to the Employee without an obligation to hold it in confidence prior to the time such Confidential Information was disclosed to the Employee by the Company; is disclosed or used, as applicable, with the prior written consent of the Company and in accordance with any limitations or conditions on such disclosure or use that may be imposed in such written consent; or was or is independently developed by the Employee without any use of or reference to the Confidential Information. In addition, notwithstanding any other language in this Agreement to the contrary, the Employee understands that the Employee may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (a) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney if such disclosure is made solely for the purpose of reporting or investigating a suspected violation of law or for pursuing an anti-retaliation lawsuit; or (b) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal and the Employee does not disclose the trade secret except pursuant to a court order.
4.4 Return of Confidential Information and the Company’s Property. When the Employee’s employment terminates with the Company, regardless of the reason for such termination, the Employee will promptly turn over to the Company in good condition all Company property in the Employee’s possession or control, including but not limited to all originals, copies of, or electronically stored documents or other materials containing Confidential Information, regardless of who prepared them. In the case of electronically stored information retained by the Employee outside of the Company’s electronic systems, the Employee will promptly make a hard copy of such information in paper, audio recording, disc format, or other format as appropriate, turn that hard copy over to the Company, and then destroy the Employee’s electronically stored information.
5. Restrictive Covenants. Employee acknowledges and agrees that some activities by Employee would, by their nature and irrespective of Employee’s intent, involve conversion of Company trade secrets and other Confidential Information, technologies, products and services, and key business relationships to the unfair advantage of competitors if engaged in shortly after Employee’s employee ends. To avoid the irreparable harm that would be caused by conduct of this nature, Employee agrees to the following reasonable limitations after Employee’s employment with the Company ends for any reason:
5.1 Non-Competition. During the Employee’s employment with the Company and for a period of twelve (12) months after the Employee’s termination of employment with the Company, regardless of the reason for such termination, the Employee agrees that the Employee shall not, directly or indirectly, provide services to or be associated with a Competitor in any role or position, including as an employee, director, owner, consultant or otherwise, that would involve Competitive Activity within the United States. For purposes of this Agreement, “Competitor” refers to a person or entity who is engaged in (or is planning or preparing to engage in) the Company’s line of business, and is in the business or producing or providing products or services that displace the business opportunities for the Company’s products and/or services, or otherwise compete with them, and “Competitive Activity” refers to business-related activity on behalf of a Competitor that involves (i) providing, supervising, or managing services that are the same as or similar in function or purpose to those Employee provided, supervised, or managed for the Company during the then immediately prior two (2) year period, (ii) assisting in the creation, development, or improvement of products or services that compete with those of the Company, (iii) accepting competing business from any customer of the Company or assisting in servicing any customer of the Company for a Competitor, (iv) owning or operating a Competitor, or (v) undertaking any other duties or responsibilities that would be likely (whether intentional or not) to require or result in the use or disclosure of Confidential Information for the benefit of a Competitor. Competitive Activity shall not include business-related activities that solely involve a product or service provided by a segment of the Company’s business that Employee had no involvement with or access to Confidential Information about in the course of Employee’s employment with the Company.
| 4 |
5.2 Non-Solicitation of Customers. During the Employee’s employment with the Company and for a period of twelve (12) months after the Employee’s termination of employment with the Company, regardless of the reason for such termination, the Employee agrees that the Employee shall not, directly or indirectly, solicit business from, work for, or otherwise interfere with or attempt to interfere with the Company’s relationship with (a) any customer of the Company or (b) any then-active material customer prospect of the Company known to Employee.
5.3 Non-Solicitation of Employees or Business Contacts. During the Employee’s employment with the Company and for a period of twelve (12) months after the Employee’s termination of employment with the Company, regardless of the reason for such termination, the Employee agrees that the Employee shall not, directly or indirectly, take any action to encourage, solicit, or recruit any current or former employee, consultant, independent contractor, subcontractor, supplier, vendor, or other business relation of the Company to terminate their relationship with the Company.
5.4 Disclosure of Obligations. Employee agrees that, during the Employee’s employment with the Company and for a period of twelve (12) months after the Employee’s termination of employment with the Company, regardless of the reason for such termination, the Employee shall, prior to accepting employment or any other business relationship with any other person or entity, inform that person or entity of the Employee’s obligations under Section 4 and this Section 5, including all of its subparts.
6. Assignment of Work Product. To the full extent permitted by applicable law, Employee hereby irrevocably assigns, grants, conveys, and otherwise transfers to the Company, and the Company’s respective successors and assigns, all of Employee’s Intellectual Property Rights in and to the Work Product (past, present, and future, including with respect to any period of Employee’s employment with the Company prior to the date of this Agreement), with no requirement of further consideration from or action by Employee or the Company. For purposes of this Agreement, “Work Product” means any inventions, original works of authorship, copyright eligible works, ideas, improvements, discoveries, unique or proprietary business methods, mask-works, formulas, algorithms, source code or software, innovations, discoveries, derivative works and patentable and unpatentable inventions and improvements, all copies of such works in whatever medium such copies are fixed or embodied, and all worldwide copyrights, trademarks, patents or other intellectual property rights in and to such intellectual property that Employee has conceived, developed, discovered, or created, or that Employee conceives, develops, discovers, or creates, while employed with a Company entity (including during any period of Employee’s employment with the Company prior to the date of this Agreement), during or after regular work hours, and on or off the Company premises that (a) relate to the Company’s business, or its actual or demonstrably anticipated research and/or development activities, (b) result from work performed for the Company, or (c) involve the use of resources of the Company. For purposed of this Agreement, “Intellectual Property Rights” means all intellectual property rights throughout the world, including, without limitation, (i) all rights relating to the protection of inventions, including patents, patent applications and invention disclosures; (ii) all rights in works of authorship, copyrightable works, registered and unregistered copyrights, all rights to databases and data collections, and registrations and applications for registration thereof; (iii) all rights in registered and unregistered trademarks, and registrations and applications for registration thereof, together with all goodwill associated therewith; (iv) all rights relating to the protection of trade secrets, know-how and proprietary information; (v) all moral and economic rights of authors and inventors, however denominated, throughout the world; (vi) all rights to obtain renewals, reissues, reexaminations, continuations, continuations-in-part, divisions or other extensions of legal protections pertaining thereto; (vii) all claims or causes of action arising out of or related to any infringement or misappropriation of any of the foregoing; and (viii) any right analogous to the forgoing
| 5 |
7. Compliance and Remedies. The Employee recognizes that if the Employee violates this Agreement, including but not limited to Sections 4 and 5 of this Agreement, irreparable damage will result to the Company that could not adequately be remedied by monetary damages. As a result, the Employee hereby agrees that notwithstanding any other dispute resolution provisions of this Agreement, in the event of any breach by the Employee of this Agreement, including but not limited to Sections 4 and 5 of this Agreement, the Company shall be entitled, in addition to any other legal or equitable remedies available to it, to an injunction to restrain the Employee’s violation of any portion of this Agreement
8. Termination of Employment.
8.1 Termination of Employment Events. Employee’s employment with the Company is at-will. Employee’s employment with the Company will terminate as follows:
|
| (a) | Upon the effective date following written notice from the Company of the termination of Employee’s employment as specified herein; |
|
|
|
|
|
| (b) | Upon Employee’s abandonment of Employee’s employment or the effective date of Employee’s resignation for any reason; |
|
|
|
|
|
| (c) | After thirty (30) days’ advance written notice to Employee by the Company of termination of Employee’s employment for Employee’s Disability (as defined below); or |
|
|
|
|
|
| (d) | Immediately upon Employee’s death. |
8.2 Termination Date. The date upon which Employee’s termination of employment with the Company is effective is the “Termination Date.” For purposes of Section 9.1 only, with respect to the timing of the Severance Payments and the Benefits Continuation Payments, the Termination Date means the date on which a “separation from service” has occurred for purposes of Section 409A of the Internal Revenue Code, as amended, and the regulations and guidance thereunder (the “Code”).
9. Payments Upon Termination of Employment.
9.1 Termination of Employment by the Company Without Cause or by Employee for Good Reason. If Employee’s employment with the Company is terminated during the Term by the Company for any reason other than for Cause (as defined in Section 9.3), or if Employee’s employment with the Company is terminated during the Term by Employee for Good Reason (as defined in Section 9.5), then the Company shall, in addition to paying Employee’s Base Salary and other compensation and benefits earned through the Termination Date, and subject to Section 9.7,
|
| (a) | pay to Employee as severance pay an amount equal to the sum of (i) fifty percent (50%) of Employee’s annualized Base Salary as of the Termination Date, less all legally required and authorized deductions and withholdings, payable in substantially equal installments in accordance with the Company’s regular payroll cycle during the six (6) month period immediately following the Termination Date, provided, however, that any installments that otherwise would be payable on the Company’s regular payroll dates between the Termination Date and the 45th calendar day after the Termination Date will be delayed until the Company’s first regular payroll date that is after the expiration of all rescission periods identified in the Release (as defined in Section 9.7) but in no event later than seventy-five (75) days after the Termination Date and included with the installment payable on such payroll date (the “Severance Payments”); and |
| 6 |
|
| (b) | if Employee is eligible for and takes all steps necessary to continue Employee’s group health insurance coverage with the Company following the Termination Date (including completing and returning the forms necessary to elect COBRA coverage), pay for the portion of the premium costs for such coverage that the Company would pay if Employee remained employed by the Company, at the same level of coverage that was in effect as of the Termination Date, through the earliest of: (i) the six (6) month anniversary of the Termination Date, (ii) the date Employee becomes eligible for group health insurance coverage from any other employer, or (iii) the date Employee is no longer eligible to continue Employee’s group health insurance coverage with the Company under applicable law (the “Benefits Continuation Payments”). |
9.2 Other Termination of Employment Events. If Employee’s employment with the Company is terminated by the Company or Employee for any reason upon or following the expiration of the Term, or if Employee’s employment with the Company is terminated during the Term by reason of:
|
| (a) | Employee’s abandonment of Employee’s employment or Employee’s resignation for any reason other than Good Reason; |
|
|
|
|
|
| (b) | termination of Employee’s employment by the Company for Cause; or |
|
|
|
|
|
| (c) | Employee’s death or Disability, |
then the Company shall pay to Employee or Employee’s beneficiary or Employee’s estate, as the case may be, Employee’s Base Salary and other compensation earned through the Termination Date and Employee shall not be eligible or entitled to receive any severance pay or benefits from the Company.
9.3 Cause Defined. “Cause” hereunder means:
|
| (a) | Employee’s material failure to perform Employee’s job duties competently as reasonably determined by the ; |
|
|
|
|
|
| (b) | gross misconduct by Employee which the Company’s Board of Managers (the “Board”) determines is (or will be if continued) demonstrably and materially damaging to the Company; |
|
|
|
|
|
| (c) | fraud, misappropriation, or embezzlement by Employee; |
|
|
|
|
|
| (d) | conviction of a felony crime or a crime of moral turpitude; |
|
|
|
|
|
| (e) | conduct in the course of employment that the Board determines is unethical; or |
|
|
|
|
|
| (f) | the material breach by Employee of this Agreement or any other written agreement between the Company and Employee. |
With respect to Section 9.3(a), Section 9.3(b) and Section 9.3(e), the Company shall first provide Employee with written notice and an opportunity to cure such breach, if curable, in the reasonable discretion of the Board, and identify with specificity the action needed to cure within thirty (30) days of Employee’s receipt of written notice from the Company. If the Company terminates Employee’s employment for Cause pursuant to this Section 9.3, then Employee shall not be eligible or entitled to receive any severance pay or benefits from the Company.
| 7 |
9.4 Disability Defined. “Disability” hereunder means the inability of Employee to perform on a full-time basis, with or without reasonable accommodation, the duties and responsibilities of Employee’s employment with the Company by reason of Employee’s illness or other physical or mental impairment or condition, if such inability continues for an uninterrupted period of at least one hundred (100) days or more during any 360-day period. A period of inability shall be “uninterrupted” unless and until Employee returns to full-time work for a continuous period of at least thirty (30) days. This Section 9.4 does not relieve the Company of any duty to reasonably accommodate a qualifying disability under the Americans with Disabilities Act, any legal duty under the Family Medical Leave Act, or any of its other duties pursuant to applicable law.
9.5 Good Reason Defined. “Good Reason” hereunder means the initial occurrence of any of the following without Employee’s consent: (a) a material and adverse change in Employee’s duties, title or position, provided, however, that a change in the Company’s status as a publicly held corporation filing reports with the Securities and Exchange Commission shall not be deemed to constitute Good Reason hereunder; (b) a reduction of fifteen percent (15%) or more by the Company in Employee’s Base Salary except for across-the-board salary reductions similarly affecting all senior executive officers of the Company; or (c) a material breach by the Company of its obligations under this Agreement; provided, however, Good Reason shall not exist unless Employee has provided notice of the existence of the Good Reason condition within ninety (90) days of the date Employee learns of the condition, the Company fails to reasonable cure such condition within thirty (30) days after the Company’s receipt of such notice, and the Termination Date occurs within thirty (30) days after the expiration of the Company’s cure period.
9.6 The Company’s Sole Obligation. In the event of termination of Employee’s employment, the sole obligation of the Company shall be its obligation to make the payments called for by Section 9.1 or Section 9.2 (as applicable), and the Company shall have no other obligation to Employee or to Employee’s beneficiary or Employee’s estate, except for any amounts due under the terms of any employee benefit plans or programs then maintained by the Company in which Employee participates.
9.7 Conditions To Receive the Severance Payments and the Benefits Continuation Payments. Notwithstanding the foregoing provisions of this Section 9, the Company will not be obligated to make the Severance Payments or the Benefits Continuation Payments under Section 9.1 to Employee unless (a) Employee signs a release of claims in favor of the Company in a form to be prescribed by the Company (the “Release”), (b) all applicable consideration periods and rescission periods provided by law with respect to the Release have expired without Employee rescinding the Release, and (c) Employee is in strict compliance with the terms of this Agreement and any other written agreement between Employee and the Company.
10. Section 409A and Taxes Generally.
10.1 Taxes. The Company shall be entitled to withhold on and report the making of such payments as may be required by law as determined in the reasonable discretion of the Company. Except for any tax amounts withheld by the Company from any compensation that Employee may receive in connection with Employee’s employment with the Company and any employer taxes required to be paid by the Company under applicable laws or regulations, Employee is solely responsible for payment of any and all taxes owed in connection with any compensation, benefits, reimbursement amounts or other payments Employee receives from the Company under this Agreement or otherwise in connection with Employee’s employment with the Company. The Company does not guarantee any particular tax consequence or result with respect to any payment made by the Company.
| 8 |
10.2 Section 409A. This Agreement is intended to provide for payments that satisfy, or are exempt from, the requirements of Section 409A, including Sections 409A(a)(2), (3) and (4) of the Code and current and future guidance and regulations interpreting such provisions, and should be interpreted accordingly. In furtherance of the foregoing, the provisions set forth below shall apply notwithstanding any other provision in this Agreement:
(a) all payments to be made to Employee hereunder, to the extent they constitute a deferral of compensation subject to the requirements of Section 409A (after taking into account all exclusions applicable to such payments under Section 409A), shall be made no later, and shall not be made any earlier, than at the time or times specified in this Agreement or in any applicable plan for such payments to be made, except as otherwise permitted or required under Section 409A;
(b) the date of Employee’s “separation from service”, as defined in Section 409A (and as determined by applying the default presumptions in Treas. Reg. §1.409A-1(h)(1)(ii)), shall be treated as the date of Employee’s termination of employment for purposes of determining the time of payment of any amount that becomes payable to Employee related to Employee’s termination of employment under Section 9.1, and any reference to Employee’s “Termination Date” or “termination” of Employee’s employment in Section 9.1, shall mean the date of Employee’s “separation from service”, as defined in Section 409A (and as determined by applying the default presumptions in Treas. Reg. §1.409A-1(h)(1)(ii));
(c) in the case of any amounts payable to Employee under this Agreement that may be treated as payable in the form of “a series of installment payments”, as defined in Treas. Reg. §1.409A-2(b)(2)(iii), Employee’s right to receive such payments shall be treated as a right to receive a series of separate payments for purposes of Treas. Reg. §1.409A-2(b)(2)(iii);
(d) to the extent that the reimbursement of any expenses eligible for reimbursement or the provision of any in-kind benefits under any provision of this Agreement would be considered deferred compensation under Section 409A (after taking into account all exclusions applicable to such reimbursements and benefits under Section 409A): (i) reimbursement of any such expense shall be made by the Company as soon as practicable after such expense has been incurred, but in any event no later than December 31st of the year following the year in which Employee incurs such expense; (ii) the amount of such expenses eligible for reimbursement, or in-kind benefits to be provided, during any calendar year shall not affect the amount of such expenses eligible for reimbursement, or in-kind benefits to be provided, in any calendar year; and (iii) Employee’s right to receive such reimbursements or in-kind benefits shall not be subject to liquidation or exchange for another benefit;
(e) to the extent any payment or delivery otherwise required to be made to Employee hereunder on account of Employee’s separation from service is properly treated as a deferral of compensation subject to Section 409A after taking into account all exclusions applicable to such payment and delivery under Section 409A, and if Employee is a “specified employee” under Section 409A at the time of Employee’s separation from service, then such payment and delivery shall not be made prior to the first business day after the earlier of (i) the expiration of six months from the date of Employee’s separation from service, or (ii) the date of Employee’s death (such first business day, the “Delayed Payment Date”), and on the Delayed Payment Date, there shall be paid or delivered to Employee or, if Employee has died, to Employee’s estate, in a single payment or delivery (as applicable) all entitlements so delayed, and in the case of cash payments, in a single cash lump sum, an amount equal to aggregate amount of all payments delayed pursuant to the preceding sentence. Except for any tax amounts withheld by the Company from the payments or other consideration hereunder and any employment taxes required to be paid by the Company, Employee shall be responsible for payment of any and all taxes owed in connection with the consideration provided for in this Agreement; and
| 9 |
(f) the Parties agree that this Agreement may be amended, as may be necessary to fully comply with, or to be exempt from, Section 409A and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost to either Party.
11. Miscellaneous.
11.1 Entire Agreement. This Agreement and the 2024 Bonus Plan contain the entire agreement and understanding among the Company and the Employee relative to subject matter hereof and supersedes all prior agreements and understandings relating to such subject matter, including but not limited to the Prior Employment Agreement and the Bonus Agreement.
11.2 Applicable Law. All matters relating to the interpretation, construction, application, validity, and enforcement of this Agreement are governed by the laws of the State of Virginia without giving effect to any choice or conflict of law provision or rule, whether of the State of Virginia or any other jurisdiction, that would cause the application of laws of any jurisdiction other than the State of Virginia.
11.3 Choice of Jurisdiction. Employee and the Company consent to jurisdiction of the state and/or federal courts of Virginia, for the purpose of resolving all issues of law, equity, or fact, arising out of or in connection with this Agreement or Employee’s employment with the Company or the termination of such employment. Any action involving claims for interpretation, breach, or enforcement of this Agreement or related to Employee’s employment with the Company or the termination of such employment shall be brought in such courts. Each Party consents to personal jurisdiction over such Party in the state and/or federal courts of Virginia and hereby waives any defense of lack of personal jurisdiction or inconvenient forum.
11.5 Counterparts. This Agreement may be executed in several counterparts and as so executed shall constitute one agreement binding on the Parties.
11.6 Assignment and Successors. The rights and obligations of the Company under this Agreement shall inure to the benefit of and will be binding upon the successors and assigns of the Company, provided any such successor or assignee assumes all of the Company’s obligations under this Agreement. Neither Party may, without the written consent of the other Party, assign or delegate any of its rights or obligations under this Agreement except that the Company may, without any further consent of Employee, assign or delegate any of its rights or obligations under this Agreement to any Company or other business entity (a) with which the Company may merge or consolidate, (b) to which the Company may sell or transfer all or substantially all of its assets or capital stock or equity, or (c) any affiliate or subsidiary of the Company. After any such assignment or delegation by the Company, the Company will be discharged from all further liability hereunder and such assignee will thereafter be deemed to be the “Company” for purposes of all terms and conditions of this Agreement, including this Section 11.6. Employee may not assign this Agreement or any rights or obligations hereunder. Any purported or attempted assignment or transfer by Employee of this Agreement or any of Employee’s duties, responsibilities, or obligations hereunder is void.
| 10 |
11.7 Modification. This Agreement shall not be modified or amended except by a written instrument signed by the Parties. In addition, no waiver of any provision of this Agreement shall be binding unless set forth in a writing signed by the Party effecting the waiver. Any waiver shall be limited to the circumstance or event specifically referenced in the written waiver document and shall not be deemed a waiver of any other term of this Agreement or of the same circumstance or event upon any recurrence thereof.
11.8 Severability. The invalidity or partial invalidity of any portion of this Agreement shall not invalidate the remainder thereof, and said remainder shall remain in full force and effect. Moreover, if one or more of the provisions contained in this Agreement shall, for any reason, be held to be excessively broad as to scope, activity, subject or otherwise, so as to be unenforceable at law, such provision or provisions shall be construed by the appropriate judicial body by limiting or reducing it or them, so as to be enforceable to the maximum extent compatible with then applicable law.
11.9 Notice. For the purposes of this Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when personally delivered or sent by certified mail, return receipt requested, postage prepaid, addressed to the respective addresses last given by each Party to the other, provided that all notices to the Company shall be directed to the attention of Chief Executive Officer of the Company, 2259 Kings Hwy, King George, VA 22485 with a copy to Chief Executive Officer of Lendway, Inc., 5000 W 36th Street, Suite 220, Minneapolis, Minnesota 55416 and all notices directed to the attention of Employee shall be directed to Craig A. Brandt, Moss & Barnett, P.A., 150 South Fifth Street, Suite 1200, Minneapolis, MN 55402. All notices and communications shall be deemed to have been received on the date of delivery thereof or on the third business day after the mailing thereof, except that notice of change of address shall be effective only upon receipt.
11.10 Counterparts. This Agreement may be executed in several counterparts and as so executed shall constitute one agreement binding on the Parties.
[Signature Page Follows]
| 11 |
THIS EMPLOYMENT AGREEMENT was voluntarily and knowingly executed by the Parties effective as of the Effective Date first set forth above.
|
|
| FRESH TULIPS USA, LLC |
|
|
|
|
|
|
| Date: February 20, 2024 |
| /s/ Randy Uglem |
|
|
|
| By: Randy Uglem |
|
|
|
| Its: Chief Executive Officer |
|
|
|
|
|
|
|
|
| EMPLOYEE: |
|
|
|
|
|
|
| Date: February 16, 2024 |
| s/ Werner Frank Jansen |
|
|
|
| Werner Frank Jansen |
|
| 12 |
EXHIBIT 10.2
2024 Bonus Plan
Werner Frank Jansen
Personal & Confidential
Werner Frank Jansen
8610 South Fork Court
Fredericksburg, VA 22407
Effective Date: February 19, 2024
BONUS PLAN
This bonus plan letter (the “Bonus Plan”) memorializes the terms and conditions of your cash incentive compensation as an employee of Fresh Tulips USA, LLC, a Virginia limited liability company (the “Company”) for the Company’s fiscal year ending June 30, 2024 (“FY24”).
The Company has, after consideration of the FY24 performance targets proposed by the Company’s management, adopted the FY24 performance goals and resulting bonus payout structure for FY24 identified below.
You will not earn or receive any annual cash incentive bonus payment for FY24 under this Bonus Plan (the “Bonus”) unless: (1) the Company has an unrestricted cash balance in excess of $2 million as of June 30, 2024 (after taking into account appropriate adjustments to normalize accounts payable consistent with historical practices, each of which will be determined in the Company’s sole discretion), (2) the EBITDA Performance (as defined below) is at least 80%; and (3) you remain employed by the Company as of the date any Bonus awarded for FY24 is paid, which will be no later than September 15, 2024.
Your target Bonus payout for FY24 is $150,000.00 (One Hundred and Fifty Thousand Dollars and Zero Cents) (the “Target”), which represents 50% of your current annual base salary (your “Base Salary”).
Financial performance for the Bonus calculation will be measured based upon the following percentage calculation for FY24 (the “EBITDA Performance”): the Company’s EBITDA number after giving effect to the payment of all Company bonus obligations in FY24 (“Actual EBITDA”), divided by the Company’s applicable EBITDA level established in the budget approved by the Company for FY24 (“Budget EBITDA”), derived from audited annual financial statements of the Company.
Your Bonus amount for FY24 will be determined based on the EBITDA Performance (the Company’s Actual EBITDA against the Company’s Budget EBITDA for FY24), with you being eligible to earn a Bonus for FY24 if the Company’s EBITDA Performance is at least 80%, with the actual Bonus amount based on a straight line calculation between 80% and 100% of the Target, with each 1% of EBITDA Performance above 80% equaling 5% of the Target. For example, if the Company’s EBITDA Performance is 85%, then the Bonus will be 25% of the Target, or 12.5% of your Base Salary. If EBITDA Performance is below 80%, then no Bonus will be earned or payable to you under this Bonus Plan. The maximum Bonus you are eligible to earn for FY24 is 100% of the Target, or 50% of your Base Salary. Any calculated Bonus will be paid to you no later than September 15, 2024, subject to you remaining employed by the Company as of the date of payment of the Bonus.
In addition, you are eligible to earn an additional bonus for FY24 (the “Growth Bonus”) if EBITDA Performance exceeds 100%, with the Growth Bonus amount equal to 10% of Actual EBITDA that exceeds the Budget EBITDA for FY24, subject to you remaining employed by the Company as of the date of payment of any Growth Bonus, which will be no later than September 15, 2024. For example, if
the Company’s Actual EBITDA for FY24 is $100,000.00 above the Budget EBITDA for FY24, then the Growth Bonus will equal $10,000.00.
| 1 |
Please confirm your understanding and acceptance of the provisions in this Bonus Plan by countersigning below.
|
| FRESH TULIPS USA, LLC |
| |
|
|
|
|
|
| Date: 02/19/2024 | By: | /s/ Catriene Bekkering |
|
|
| Name: | Catriene Bekkering |
|
|
| Its: | Chief Financial Officer |
|
Acknowledgment and Acceptance:
By signing below, I accept and agree to the terms and conditions of this Bonus Plan concerning my incentive bonus opportunity for FY24 as set forth above.
| Date: 02/19/2024 | /s/ Werner Frank Jansen |
|
|
| Werner Frank Jansen |
|
| 2 |
EXHIBIT 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
I, Randy D. Uglem, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Lendway, Inc.; |
|
|
|
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
|
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
|
| 4. | The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
| a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within the registrant, particularly during the period in which this report is being prepared; and |
|
|
|
|
|
| b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and |
|
|
|
|
|
| c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
|
| d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; |
| 5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): | |
|
|
|
|
|
| a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|
|
|
|
|
| b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting. |
| Date: May 21, 2024 | /s/ Randy D. Uglem |
|
|
| Randy D. Uglem |
|
|
| President and Chief Executive Officer |
|
|
| (principal executive officer) |
|
EXHIBIT 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
I, Zackery A. Weber, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Lendway, Inc.; |
|
|
|
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
|
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
|
| 4. | The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
| a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within the registrant, particularly during the period in which this report is being prepared; and |
|
|
|
|
|
| b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and |
|
|
|
|
|
| c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
|
| d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; |
|
|
|
|
| 5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): | |
|
|
|
|
|
| a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|
|
|
|
|
| b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting. |
| Date: May 21, 2024 | /s/ Zackery A. Weber |
|
|
| Zackery A. Weber |
|
|
| Vice President of Finance |
|
|
| (principal financial and accounting officer) |
|
EXHIBIT 32
SECTION 1350 CERTIFICATION
The undersigned certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The accompanying Quarterly Report on Form 10-Q for the period ended March 31, 2024, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
| (2) | The information contained in the accompanying Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: May 21, 2024 | /s/ Randy D. Uglem |
|
|
| Randy D. Uglem |
|
|
| President and Chief Executive Officer |
|
|
| (principal executive officer) |
|
|
|
|
|
| Date: May 21, 2024 | /s/ Zackery A. Weber |
|
|
| Zackery A. Weber |
|
|
| Vice President of Finance |
|
|
| (principal financial and accounting officer) |
|